User login
Marjolin Ulcer in a Surgical Scar
To the Editor:
Marjolin ulcers are malignancies arising in nonhealing cutaneous wounds. Although burn wounds are the most common type of cutaneous trauma associated with this entity, there are a multitude of possible lesions that may initiate this disease process including traumatic wounds, venous stasis ulcers, and vaccination sites.1,2 The most common type of malignancy reported in a Marjolin ulcer is an aggressive squamous cell carcinoma (SCC).1-3 Less commonly, basal cell carcinoma (BCC) also has been reported.1,3,4 However, cases of BCCs developing in surgical scars are exceedingly rare. We describe a case of a morphoeic BCC in a long-standing surgical scar in a 50-year-old woman with Crohn disease.
A 50-year-old woman presented with an intermittent ulceration within a horizontal surgical scar on the right side of the upper abdomen of 2 years’ duration that had not healed over the course of the last 6 months. The scar was present from surgeries conducted while she was a teenager for complications associated with Crohn disease. She underwent her first abdominal surgery for a partial gastric resection at 16 years of age, followed by multiple laparotomies from a perforated bile duct that occurred during the first surgery. The original incision created for the partial gastric resection was used for all subsequent surgeries.
The patient’s medical history was notable for central nervous system vasculitis with vision loss, chronic pancreatitis, Crohn disease, arthritis, multiple superficial BCCs on the back that were successfully treated with imiquimod cream, a nodular BCC on the neck that was surgically removed, and facial actinic keratoses treated with liquid nitrogen. She had Fitzpatrick skin type I. She grew up in a residential area in Southern Ontario and did not have a history of heavy sun exposure. She did not receive notable radiation from treatment of Crohn disease, and she usually wore a 1-piece bathing suit when swimming outdoors. According to the patient, she had never been exposed to arsenic. The patient’s family history was negative for skin cancer and she was a nonsmoker. She was taking methotrexate, prednisone, folic acid, pentazocine, and vitamin B12 injections at the time of presentation for the aforementioned conditions.
On physical examination a 1.5-cm honey-crusted ulcer with surrounding violaceous erythema in a long-standing surgical scar was observed (Figure 1). There was no palpable adenopathy in the inguinal or axillary regions. The suspected diagnosis prebiopsy was an SCC developing within the scar tissue. On histologic examination sections of small nests and strands of basal cell infiltrating thick collagen bundles were visualized. The appearance was consistent with a morphoeic BCC. The pathologist’s interpretation indicated that the lesion appeared to be a morphoeic BCC within the scar as opposed to a BCC that appeared morphoeic because of background scarring. Histologic images stained with hematoxylin and eosin showed small nests and strands of basal cells penetrating thick collagen bundles (Figure 2).
![]() ![]() |
|
Marjolin ulcer was first described in 1828 by the French surgeon Jean-Nicolas Marjolin who published 4 cases of ulcers arising from scar tissue but did not appreciate their malignant capacity. However, the term Marjolin ulcer is now widely accepted as meaning any malignant tumor occurring within scar tissue or a chronic nonhealing wound.1,2
The exact incidence of malignant transformation in cutaneous wounds remains unknown, but this phenomenon can occur in individuals of all races and across all age groups.1,5-7 The most prevalent malignancy identified on biopsy is SCC, followed by BCC, melanoma, osteosarcoma, fibrosarcoma, and liposarcoma.1,2,6,7 With this entity infrequently occurring in the clinical setting, it often is overlooked or misdiagnosed.2 In addition, malignancies presenting as Marjolin ulcers have a greater tendency to metastasize and are reported to have a higher associated fatality rate.2,8 Thus, early recognition is essential, as a delay in diagnosis can potentially allow the tumor to progress to a life-threatening stage. In our patient, malignancy was clinically suspected based on the presence of an ulcer that was not healing despite adequate wound care and the location in a scar that was present for more than 30 years. The surgical scar had been a place of repeated trauma given the number of surgical procedures and the perforated bile duct, which can increase the potential for malignant transformation. Furthermore, the patient also was on immunosuppressive therapy for an extended period of time, possibly contributing to the development of this cancerous lesion and prior cutaneous malignancies.
The pathogenesis of a Marjolin ulcer is unclear, though many hypotheses have been suggested.1,2,6,9 Theories investigating decreased vascularity, lowered immune surveillance, decreased regenerative capacity, genetic mutations, and injury-related release of toxins have all been postulated as possible explanations for the increase in potential of malignant transformation.1-3,6,9 However, despite the pathogenesis, the mainstay of treatment remains wide local excision with at least 2-cm margins.1-3,10 Alternatively, Mohs micrographic surgery can be considered for Marjolin ulcers, but it is less frequently conducted in comparison to wide local excision. Radiation therapy often follows excision as adjuvant therapy, depending on the type of tumor.2,10 Prophylactic lymph node dissection is not indicated in most cases, but regional node dissection is suggested when palpable lymphadenopathy is present.1,2,10 Moreover, amputation is indicated with deep bone or joint involvement.1-3,10 Recurrence rates are high, ranging from 20% to 50%, and metastases to the brain, liver, lungs, kidneys, and lymph nodes have been reported.1,3 The prognosis of the cutaneous malignancy in this setting is not as favorable, and the 5-year survival rate is cited at approximately 60%.3 Overall prognosis depends on several factors including location, type of malignancy, immune status, progression of disease, and lymph node metastasis. Our patient’s presentation with a BCC instead of the more common SCC should carry a good overall prognosis, though she will need to be closely followed for recurrence after wide local excision.
This novel presentation of a morpheaform BCC in a surgical scar may serve as a reminder to consider this diagnosis and biopsy nonhealing ulcers within any type of chronic wound or scar.
1. Daya M, Balakrishan T. Advanced Marjolin’s ulcer of the scalp in a 13-year-old boy treated by excision and free tissue transfer: case report and review of literature. Indian J Plast Surg. 2009;42:106-111.
2. Pavlovic S, Wiley E, Guzman G, et al. Marjolin ulcer: an overlooked entity [published online ahead of print May 17, 2011]. Int Wound J. 2011;8:419-424.
3. Asuquo M, Ugare G, Ebughe G, et al. Marjolin’s ulcer: the importance of surgical management of chronic cutaneous ulcers. Int J Dermatol. 2007;46(suppl 2):S29-S32.
4. Ogawa B, Chen M, Margolis J, et al. Marjolin’s ulcer arising at the elbow: a case report and literature review. Hand (N Y). 2006;1:89-93.
5. Dupree MT, Boyer JD, Cobb MW. Marjolin’s ulcer arising in a burn scar. Cutis. 1998;62:49-51.
6. Er-Fan X, Li AO, Shi-ling W, et al. Burn scar carcinoma: case reports and review of the literature. Ann MBC. 1992;5:2.
7. Malheiro E, Pinto A, Choupina M, et al. Marjolin’s ulcer of the scalp: case report and literature review. Ann Burns and Fire Disasters. 2001;14:115-118.
8. Ozek C, Celik N, Bilkay U, et al. Marjolin’s ulcer of the scalp: report of 5 cases and review of the literature. J Burn Care Rehabil. 2001;22:65-69.
9. Thio D, Clarkson JH, Misra A, et al. Malignant change after 18 months in a lower limb ulcer: acute Marjolin’s revisited. Br J Plast Surg. 2003;56:825-828.
10. Aydogdu E, Yildirim S, Aköz T. Is surgery an effective and adequate treatmegnt in advanced Marjolin’s ulcer [published online ahead of print April 1, 2005]? Burns. 2005;31:421-431.
To the Editor:
Marjolin ulcers are malignancies arising in nonhealing cutaneous wounds. Although burn wounds are the most common type of cutaneous trauma associated with this entity, there are a multitude of possible lesions that may initiate this disease process including traumatic wounds, venous stasis ulcers, and vaccination sites.1,2 The most common type of malignancy reported in a Marjolin ulcer is an aggressive squamous cell carcinoma (SCC).1-3 Less commonly, basal cell carcinoma (BCC) also has been reported.1,3,4 However, cases of BCCs developing in surgical scars are exceedingly rare. We describe a case of a morphoeic BCC in a long-standing surgical scar in a 50-year-old woman with Crohn disease.
A 50-year-old woman presented with an intermittent ulceration within a horizontal surgical scar on the right side of the upper abdomen of 2 years’ duration that had not healed over the course of the last 6 months. The scar was present from surgeries conducted while she was a teenager for complications associated with Crohn disease. She underwent her first abdominal surgery for a partial gastric resection at 16 years of age, followed by multiple laparotomies from a perforated bile duct that occurred during the first surgery. The original incision created for the partial gastric resection was used for all subsequent surgeries.
The patient’s medical history was notable for central nervous system vasculitis with vision loss, chronic pancreatitis, Crohn disease, arthritis, multiple superficial BCCs on the back that were successfully treated with imiquimod cream, a nodular BCC on the neck that was surgically removed, and facial actinic keratoses treated with liquid nitrogen. She had Fitzpatrick skin type I. She grew up in a residential area in Southern Ontario and did not have a history of heavy sun exposure. She did not receive notable radiation from treatment of Crohn disease, and she usually wore a 1-piece bathing suit when swimming outdoors. According to the patient, she had never been exposed to arsenic. The patient’s family history was negative for skin cancer and she was a nonsmoker. She was taking methotrexate, prednisone, folic acid, pentazocine, and vitamin B12 injections at the time of presentation for the aforementioned conditions.
On physical examination a 1.5-cm honey-crusted ulcer with surrounding violaceous erythema in a long-standing surgical scar was observed (Figure 1). There was no palpable adenopathy in the inguinal or axillary regions. The suspected diagnosis prebiopsy was an SCC developing within the scar tissue. On histologic examination sections of small nests and strands of basal cell infiltrating thick collagen bundles were visualized. The appearance was consistent with a morphoeic BCC. The pathologist’s interpretation indicated that the lesion appeared to be a morphoeic BCC within the scar as opposed to a BCC that appeared morphoeic because of background scarring. Histologic images stained with hematoxylin and eosin showed small nests and strands of basal cells penetrating thick collagen bundles (Figure 2).
![]() ![]() |
|
Marjolin ulcer was first described in 1828 by the French surgeon Jean-Nicolas Marjolin who published 4 cases of ulcers arising from scar tissue but did not appreciate their malignant capacity. However, the term Marjolin ulcer is now widely accepted as meaning any malignant tumor occurring within scar tissue or a chronic nonhealing wound.1,2
The exact incidence of malignant transformation in cutaneous wounds remains unknown, but this phenomenon can occur in individuals of all races and across all age groups.1,5-7 The most prevalent malignancy identified on biopsy is SCC, followed by BCC, melanoma, osteosarcoma, fibrosarcoma, and liposarcoma.1,2,6,7 With this entity infrequently occurring in the clinical setting, it often is overlooked or misdiagnosed.2 In addition, malignancies presenting as Marjolin ulcers have a greater tendency to metastasize and are reported to have a higher associated fatality rate.2,8 Thus, early recognition is essential, as a delay in diagnosis can potentially allow the tumor to progress to a life-threatening stage. In our patient, malignancy was clinically suspected based on the presence of an ulcer that was not healing despite adequate wound care and the location in a scar that was present for more than 30 years. The surgical scar had been a place of repeated trauma given the number of surgical procedures and the perforated bile duct, which can increase the potential for malignant transformation. Furthermore, the patient also was on immunosuppressive therapy for an extended period of time, possibly contributing to the development of this cancerous lesion and prior cutaneous malignancies.
The pathogenesis of a Marjolin ulcer is unclear, though many hypotheses have been suggested.1,2,6,9 Theories investigating decreased vascularity, lowered immune surveillance, decreased regenerative capacity, genetic mutations, and injury-related release of toxins have all been postulated as possible explanations for the increase in potential of malignant transformation.1-3,6,9 However, despite the pathogenesis, the mainstay of treatment remains wide local excision with at least 2-cm margins.1-3,10 Alternatively, Mohs micrographic surgery can be considered for Marjolin ulcers, but it is less frequently conducted in comparison to wide local excision. Radiation therapy often follows excision as adjuvant therapy, depending on the type of tumor.2,10 Prophylactic lymph node dissection is not indicated in most cases, but regional node dissection is suggested when palpable lymphadenopathy is present.1,2,10 Moreover, amputation is indicated with deep bone or joint involvement.1-3,10 Recurrence rates are high, ranging from 20% to 50%, and metastases to the brain, liver, lungs, kidneys, and lymph nodes have been reported.1,3 The prognosis of the cutaneous malignancy in this setting is not as favorable, and the 5-year survival rate is cited at approximately 60%.3 Overall prognosis depends on several factors including location, type of malignancy, immune status, progression of disease, and lymph node metastasis. Our patient’s presentation with a BCC instead of the more common SCC should carry a good overall prognosis, though she will need to be closely followed for recurrence after wide local excision.
This novel presentation of a morpheaform BCC in a surgical scar may serve as a reminder to consider this diagnosis and biopsy nonhealing ulcers within any type of chronic wound or scar.
To the Editor:
Marjolin ulcers are malignancies arising in nonhealing cutaneous wounds. Although burn wounds are the most common type of cutaneous trauma associated with this entity, there are a multitude of possible lesions that may initiate this disease process including traumatic wounds, venous stasis ulcers, and vaccination sites.1,2 The most common type of malignancy reported in a Marjolin ulcer is an aggressive squamous cell carcinoma (SCC).1-3 Less commonly, basal cell carcinoma (BCC) also has been reported.1,3,4 However, cases of BCCs developing in surgical scars are exceedingly rare. We describe a case of a morphoeic BCC in a long-standing surgical scar in a 50-year-old woman with Crohn disease.
A 50-year-old woman presented with an intermittent ulceration within a horizontal surgical scar on the right side of the upper abdomen of 2 years’ duration that had not healed over the course of the last 6 months. The scar was present from surgeries conducted while she was a teenager for complications associated with Crohn disease. She underwent her first abdominal surgery for a partial gastric resection at 16 years of age, followed by multiple laparotomies from a perforated bile duct that occurred during the first surgery. The original incision created for the partial gastric resection was used for all subsequent surgeries.
The patient’s medical history was notable for central nervous system vasculitis with vision loss, chronic pancreatitis, Crohn disease, arthritis, multiple superficial BCCs on the back that were successfully treated with imiquimod cream, a nodular BCC on the neck that was surgically removed, and facial actinic keratoses treated with liquid nitrogen. She had Fitzpatrick skin type I. She grew up in a residential area in Southern Ontario and did not have a history of heavy sun exposure. She did not receive notable radiation from treatment of Crohn disease, and she usually wore a 1-piece bathing suit when swimming outdoors. According to the patient, she had never been exposed to arsenic. The patient’s family history was negative for skin cancer and she was a nonsmoker. She was taking methotrexate, prednisone, folic acid, pentazocine, and vitamin B12 injections at the time of presentation for the aforementioned conditions.
On physical examination a 1.5-cm honey-crusted ulcer with surrounding violaceous erythema in a long-standing surgical scar was observed (Figure 1). There was no palpable adenopathy in the inguinal or axillary regions. The suspected diagnosis prebiopsy was an SCC developing within the scar tissue. On histologic examination sections of small nests and strands of basal cell infiltrating thick collagen bundles were visualized. The appearance was consistent with a morphoeic BCC. The pathologist’s interpretation indicated that the lesion appeared to be a morphoeic BCC within the scar as opposed to a BCC that appeared morphoeic because of background scarring. Histologic images stained with hematoxylin and eosin showed small nests and strands of basal cells penetrating thick collagen bundles (Figure 2).
![]() ![]() |
|
Marjolin ulcer was first described in 1828 by the French surgeon Jean-Nicolas Marjolin who published 4 cases of ulcers arising from scar tissue but did not appreciate their malignant capacity. However, the term Marjolin ulcer is now widely accepted as meaning any malignant tumor occurring within scar tissue or a chronic nonhealing wound.1,2
The exact incidence of malignant transformation in cutaneous wounds remains unknown, but this phenomenon can occur in individuals of all races and across all age groups.1,5-7 The most prevalent malignancy identified on biopsy is SCC, followed by BCC, melanoma, osteosarcoma, fibrosarcoma, and liposarcoma.1,2,6,7 With this entity infrequently occurring in the clinical setting, it often is overlooked or misdiagnosed.2 In addition, malignancies presenting as Marjolin ulcers have a greater tendency to metastasize and are reported to have a higher associated fatality rate.2,8 Thus, early recognition is essential, as a delay in diagnosis can potentially allow the tumor to progress to a life-threatening stage. In our patient, malignancy was clinically suspected based on the presence of an ulcer that was not healing despite adequate wound care and the location in a scar that was present for more than 30 years. The surgical scar had been a place of repeated trauma given the number of surgical procedures and the perforated bile duct, which can increase the potential for malignant transformation. Furthermore, the patient also was on immunosuppressive therapy for an extended period of time, possibly contributing to the development of this cancerous lesion and prior cutaneous malignancies.
The pathogenesis of a Marjolin ulcer is unclear, though many hypotheses have been suggested.1,2,6,9 Theories investigating decreased vascularity, lowered immune surveillance, decreased regenerative capacity, genetic mutations, and injury-related release of toxins have all been postulated as possible explanations for the increase in potential of malignant transformation.1-3,6,9 However, despite the pathogenesis, the mainstay of treatment remains wide local excision with at least 2-cm margins.1-3,10 Alternatively, Mohs micrographic surgery can be considered for Marjolin ulcers, but it is less frequently conducted in comparison to wide local excision. Radiation therapy often follows excision as adjuvant therapy, depending on the type of tumor.2,10 Prophylactic lymph node dissection is not indicated in most cases, but regional node dissection is suggested when palpable lymphadenopathy is present.1,2,10 Moreover, amputation is indicated with deep bone or joint involvement.1-3,10 Recurrence rates are high, ranging from 20% to 50%, and metastases to the brain, liver, lungs, kidneys, and lymph nodes have been reported.1,3 The prognosis of the cutaneous malignancy in this setting is not as favorable, and the 5-year survival rate is cited at approximately 60%.3 Overall prognosis depends on several factors including location, type of malignancy, immune status, progression of disease, and lymph node metastasis. Our patient’s presentation with a BCC instead of the more common SCC should carry a good overall prognosis, though she will need to be closely followed for recurrence after wide local excision.
This novel presentation of a morpheaform BCC in a surgical scar may serve as a reminder to consider this diagnosis and biopsy nonhealing ulcers within any type of chronic wound or scar.
1. Daya M, Balakrishan T. Advanced Marjolin’s ulcer of the scalp in a 13-year-old boy treated by excision and free tissue transfer: case report and review of literature. Indian J Plast Surg. 2009;42:106-111.
2. Pavlovic S, Wiley E, Guzman G, et al. Marjolin ulcer: an overlooked entity [published online ahead of print May 17, 2011]. Int Wound J. 2011;8:419-424.
3. Asuquo M, Ugare G, Ebughe G, et al. Marjolin’s ulcer: the importance of surgical management of chronic cutaneous ulcers. Int J Dermatol. 2007;46(suppl 2):S29-S32.
4. Ogawa B, Chen M, Margolis J, et al. Marjolin’s ulcer arising at the elbow: a case report and literature review. Hand (N Y). 2006;1:89-93.
5. Dupree MT, Boyer JD, Cobb MW. Marjolin’s ulcer arising in a burn scar. Cutis. 1998;62:49-51.
6. Er-Fan X, Li AO, Shi-ling W, et al. Burn scar carcinoma: case reports and review of the literature. Ann MBC. 1992;5:2.
7. Malheiro E, Pinto A, Choupina M, et al. Marjolin’s ulcer of the scalp: case report and literature review. Ann Burns and Fire Disasters. 2001;14:115-118.
8. Ozek C, Celik N, Bilkay U, et al. Marjolin’s ulcer of the scalp: report of 5 cases and review of the literature. J Burn Care Rehabil. 2001;22:65-69.
9. Thio D, Clarkson JH, Misra A, et al. Malignant change after 18 months in a lower limb ulcer: acute Marjolin’s revisited. Br J Plast Surg. 2003;56:825-828.
10. Aydogdu E, Yildirim S, Aköz T. Is surgery an effective and adequate treatmegnt in advanced Marjolin’s ulcer [published online ahead of print April 1, 2005]? Burns. 2005;31:421-431.
1. Daya M, Balakrishan T. Advanced Marjolin’s ulcer of the scalp in a 13-year-old boy treated by excision and free tissue transfer: case report and review of literature. Indian J Plast Surg. 2009;42:106-111.
2. Pavlovic S, Wiley E, Guzman G, et al. Marjolin ulcer: an overlooked entity [published online ahead of print May 17, 2011]. Int Wound J. 2011;8:419-424.
3. Asuquo M, Ugare G, Ebughe G, et al. Marjolin’s ulcer: the importance of surgical management of chronic cutaneous ulcers. Int J Dermatol. 2007;46(suppl 2):S29-S32.
4. Ogawa B, Chen M, Margolis J, et al. Marjolin’s ulcer arising at the elbow: a case report and literature review. Hand (N Y). 2006;1:89-93.
5. Dupree MT, Boyer JD, Cobb MW. Marjolin’s ulcer arising in a burn scar. Cutis. 1998;62:49-51.
6. Er-Fan X, Li AO, Shi-ling W, et al. Burn scar carcinoma: case reports and review of the literature. Ann MBC. 1992;5:2.
7. Malheiro E, Pinto A, Choupina M, et al. Marjolin’s ulcer of the scalp: case report and literature review. Ann Burns and Fire Disasters. 2001;14:115-118.
8. Ozek C, Celik N, Bilkay U, et al. Marjolin’s ulcer of the scalp: report of 5 cases and review of the literature. J Burn Care Rehabil. 2001;22:65-69.
9. Thio D, Clarkson JH, Misra A, et al. Malignant change after 18 months in a lower limb ulcer: acute Marjolin’s revisited. Br J Plast Surg. 2003;56:825-828.
10. Aydogdu E, Yildirim S, Aköz T. Is surgery an effective and adequate treatmegnt in advanced Marjolin’s ulcer [published online ahead of print April 1, 2005]? Burns. 2005;31:421-431.
Sports Purpura From Floorball, Indoor Climbing, and Archery
To the Editor:
Sports purpura can be broken down into different types including traumatic purpura,1 exercise-induced cutaneous vasculitis,2 occurrence of coincidental systemic purpura,3 and other conditions.4-6 Traumatic purpura results from brutal contact with an opponent, the court, the equipment, or the ball. Three cases of sports purpura related to equipment and balls are reported.
An otherwise healthy 27-year-old woman presented with multiple ecchymotic round patches on her legs. The largest patch was 70 mm and displayed a heterogeneous Swiss cheese–like pattern with discrete whiter round areas within the patch (Figure 1). She reported that she played as a defender in a second division floorball team weekly, acknowledging frequent body contacts and being hit on the legs with the sticks and balls. Purpura was diagnosed due to hits from the floorball.
A 32-year-old healthy man presented with purpuric petechiae of the left palm after indoor climbing. He had been regularly climbing indoors for 3 years and denied a history of similar eruptions. The lesions were painless, noninfiltrated, and did not disappear after pressure (Figure 2). Lesions presumably were due to repeated friction on the climbing hold. Petechiae took a transiently golden hue before resolving within a week.
![]() | ![]() |
A 26-year-old right-handed woman injured the left forearm while practicing target archery. She was not wearing an arm guard at the time of the injury. Once released, the bowstring scraped the volar aspect of the forearm, causing a painful warm ecchymotic and swollen plaque. She denied neurologic or vascular symptoms. The hematoma rapidly evolved from red to blue (Figure 3) and spontaneously resolved within weeks.
|
Purpura related to the high-velocity impact of sport balls has been previously reported with ping-pong,7 paintball,8,9 racquetball, squash,10 and baseball. Floorball, one of the most popular team sports in Finland, is played indoors and resembles ice hockey. The players use graphite compound sticks and a light hollow plastic ball. Except for the goalkeeper, players do not wear specific protective gear. Accidental body contact, including a direct hit from the floorball stick or ball, are frequent.11 The ball weighs 23 g, measures 72 mm in diameter, and has 26 holes that are 11 mm in diameter. The fastest shot was recorded at 127 miles per hour.12 The cutaneous imprint from the ball impact on bare skin, as shown with patient 1, initially is annular,8-10 but the bruise later takes an unusual design due to the peculiar shape of the ball. This complication is no stranger to floorball players but has been rarely reported. The diagnosis is easy, the condition is benign and asymptomatic, and it resolves when the season is over; therefore, players commonly will not seek medical attention. Of note, lower limb injuries, including joint sprains, muscle strains, and soft-tissue contusions, are frequent in female athletes.11 Additional causes of purpura include collision with another player or with boards and stick hits.
Palmar petechiae from indoor climbing is similar to black palm from weight lifting.13 Although the typical black discoloration is absent, the mechanisms of friction and brutal trauma, clinical presentation, and evolution are similar.
Lastly, archery-induced hematomas are caused by the absence of an arm guard, which protects the wrist and forearm when the string snaps back.14 This complication is not often reported but is known by archers. Because archers usually wear protective gear, these injuries are expected to occur in novices or when safety measures are not respected.
1. Aguayo-Leiva I, Vano-Galvan S, Arrazola JM. A purpuric rash. Aust Fam Physician. 2009;38:889-890.
2. Ramelet AA. Exercise-induced vasculitis. J Eur Acad Dermatol Venereol. 2006;20:423-427.
3. Leonard JC, Rieger M. Idiopathic thrombocytopenic purpura presenting in a high school football player: a case report. J Athl Train. 1998;33:269-270.
4. Nordlind K, Bondesson L, Johansson SG, et al. Purpura provoked by cold exposure in a skier. Dermatologica. 1983;167:101-103.
5. Latenser BA, Hempstead RW. Exercise-associated solar purpura in an atypical location. Cutis. 1985;35:365-366.
6. Allan SJ, Humphreys F, Buxton PK. Annular purpura and step aerobics. Clin Exp Dermatol. 1994;19:418.
7. Scott MJ Jr, Scott MJ 3rd. Ping pong patches. Cutis. 1989;43:363-364.
8. Aboutalebi S, Stetson CL. Paintball purpura. J Am Acad Dermatol. 2005;53:901-902.
9. Levsky ME, Crowe M. What is your diagnosis? paintball purpura. Cutis. 2005;75:148, 157-158.
10. Barazi H, Adams BB. Sports purpura. Int J Dermatol. 2006;45:1443.
11. Pasanen K, Parkkari J, Kannus P, et al. Injury risk in female floorball: a prospective one-season follow-up [published online ahead of print May 9, 2007]. Scand J Med Sci Sports. 2008;18:49-54.
12. New world record. Floorball Central Web site. http://www.floorballcentral.com/2010/11/new-world -record.html. Published November 5, 2010. Accessed April 8, 2015.
13. Izumi AK. Letter: pigmented palmar petechiae (black palm). Arch Dermatol. 1974;109:261.
14. Rayan GM. Archery-related injuries of the hand, forearm, and elbow. South Med J. 1992;85:961-964.
To the Editor:
Sports purpura can be broken down into different types including traumatic purpura,1 exercise-induced cutaneous vasculitis,2 occurrence of coincidental systemic purpura,3 and other conditions.4-6 Traumatic purpura results from brutal contact with an opponent, the court, the equipment, or the ball. Three cases of sports purpura related to equipment and balls are reported.
An otherwise healthy 27-year-old woman presented with multiple ecchymotic round patches on her legs. The largest patch was 70 mm and displayed a heterogeneous Swiss cheese–like pattern with discrete whiter round areas within the patch (Figure 1). She reported that she played as a defender in a second division floorball team weekly, acknowledging frequent body contacts and being hit on the legs with the sticks and balls. Purpura was diagnosed due to hits from the floorball.
A 32-year-old healthy man presented with purpuric petechiae of the left palm after indoor climbing. He had been regularly climbing indoors for 3 years and denied a history of similar eruptions. The lesions were painless, noninfiltrated, and did not disappear after pressure (Figure 2). Lesions presumably were due to repeated friction on the climbing hold. Petechiae took a transiently golden hue before resolving within a week.
![]() | ![]() |
A 26-year-old right-handed woman injured the left forearm while practicing target archery. She was not wearing an arm guard at the time of the injury. Once released, the bowstring scraped the volar aspect of the forearm, causing a painful warm ecchymotic and swollen plaque. She denied neurologic or vascular symptoms. The hematoma rapidly evolved from red to blue (Figure 3) and spontaneously resolved within weeks.
|
Purpura related to the high-velocity impact of sport balls has been previously reported with ping-pong,7 paintball,8,9 racquetball, squash,10 and baseball. Floorball, one of the most popular team sports in Finland, is played indoors and resembles ice hockey. The players use graphite compound sticks and a light hollow plastic ball. Except for the goalkeeper, players do not wear specific protective gear. Accidental body contact, including a direct hit from the floorball stick or ball, are frequent.11 The ball weighs 23 g, measures 72 mm in diameter, and has 26 holes that are 11 mm in diameter. The fastest shot was recorded at 127 miles per hour.12 The cutaneous imprint from the ball impact on bare skin, as shown with patient 1, initially is annular,8-10 but the bruise later takes an unusual design due to the peculiar shape of the ball. This complication is no stranger to floorball players but has been rarely reported. The diagnosis is easy, the condition is benign and asymptomatic, and it resolves when the season is over; therefore, players commonly will not seek medical attention. Of note, lower limb injuries, including joint sprains, muscle strains, and soft-tissue contusions, are frequent in female athletes.11 Additional causes of purpura include collision with another player or with boards and stick hits.
Palmar petechiae from indoor climbing is similar to black palm from weight lifting.13 Although the typical black discoloration is absent, the mechanisms of friction and brutal trauma, clinical presentation, and evolution are similar.
Lastly, archery-induced hematomas are caused by the absence of an arm guard, which protects the wrist and forearm when the string snaps back.14 This complication is not often reported but is known by archers. Because archers usually wear protective gear, these injuries are expected to occur in novices or when safety measures are not respected.
To the Editor:
Sports purpura can be broken down into different types including traumatic purpura,1 exercise-induced cutaneous vasculitis,2 occurrence of coincidental systemic purpura,3 and other conditions.4-6 Traumatic purpura results from brutal contact with an opponent, the court, the equipment, or the ball. Three cases of sports purpura related to equipment and balls are reported.
An otherwise healthy 27-year-old woman presented with multiple ecchymotic round patches on her legs. The largest patch was 70 mm and displayed a heterogeneous Swiss cheese–like pattern with discrete whiter round areas within the patch (Figure 1). She reported that she played as a defender in a second division floorball team weekly, acknowledging frequent body contacts and being hit on the legs with the sticks and balls. Purpura was diagnosed due to hits from the floorball.
A 32-year-old healthy man presented with purpuric petechiae of the left palm after indoor climbing. He had been regularly climbing indoors for 3 years and denied a history of similar eruptions. The lesions were painless, noninfiltrated, and did not disappear after pressure (Figure 2). Lesions presumably were due to repeated friction on the climbing hold. Petechiae took a transiently golden hue before resolving within a week.
![]() | ![]() |
A 26-year-old right-handed woman injured the left forearm while practicing target archery. She was not wearing an arm guard at the time of the injury. Once released, the bowstring scraped the volar aspect of the forearm, causing a painful warm ecchymotic and swollen plaque. She denied neurologic or vascular symptoms. The hematoma rapidly evolved from red to blue (Figure 3) and spontaneously resolved within weeks.
|
Purpura related to the high-velocity impact of sport balls has been previously reported with ping-pong,7 paintball,8,9 racquetball, squash,10 and baseball. Floorball, one of the most popular team sports in Finland, is played indoors and resembles ice hockey. The players use graphite compound sticks and a light hollow plastic ball. Except for the goalkeeper, players do not wear specific protective gear. Accidental body contact, including a direct hit from the floorball stick or ball, are frequent.11 The ball weighs 23 g, measures 72 mm in diameter, and has 26 holes that are 11 mm in diameter. The fastest shot was recorded at 127 miles per hour.12 The cutaneous imprint from the ball impact on bare skin, as shown with patient 1, initially is annular,8-10 but the bruise later takes an unusual design due to the peculiar shape of the ball. This complication is no stranger to floorball players but has been rarely reported. The diagnosis is easy, the condition is benign and asymptomatic, and it resolves when the season is over; therefore, players commonly will not seek medical attention. Of note, lower limb injuries, including joint sprains, muscle strains, and soft-tissue contusions, are frequent in female athletes.11 Additional causes of purpura include collision with another player or with boards and stick hits.
Palmar petechiae from indoor climbing is similar to black palm from weight lifting.13 Although the typical black discoloration is absent, the mechanisms of friction and brutal trauma, clinical presentation, and evolution are similar.
Lastly, archery-induced hematomas are caused by the absence of an arm guard, which protects the wrist and forearm when the string snaps back.14 This complication is not often reported but is known by archers. Because archers usually wear protective gear, these injuries are expected to occur in novices or when safety measures are not respected.
1. Aguayo-Leiva I, Vano-Galvan S, Arrazola JM. A purpuric rash. Aust Fam Physician. 2009;38:889-890.
2. Ramelet AA. Exercise-induced vasculitis. J Eur Acad Dermatol Venereol. 2006;20:423-427.
3. Leonard JC, Rieger M. Idiopathic thrombocytopenic purpura presenting in a high school football player: a case report. J Athl Train. 1998;33:269-270.
4. Nordlind K, Bondesson L, Johansson SG, et al. Purpura provoked by cold exposure in a skier. Dermatologica. 1983;167:101-103.
5. Latenser BA, Hempstead RW. Exercise-associated solar purpura in an atypical location. Cutis. 1985;35:365-366.
6. Allan SJ, Humphreys F, Buxton PK. Annular purpura and step aerobics. Clin Exp Dermatol. 1994;19:418.
7. Scott MJ Jr, Scott MJ 3rd. Ping pong patches. Cutis. 1989;43:363-364.
8. Aboutalebi S, Stetson CL. Paintball purpura. J Am Acad Dermatol. 2005;53:901-902.
9. Levsky ME, Crowe M. What is your diagnosis? paintball purpura. Cutis. 2005;75:148, 157-158.
10. Barazi H, Adams BB. Sports purpura. Int J Dermatol. 2006;45:1443.
11. Pasanen K, Parkkari J, Kannus P, et al. Injury risk in female floorball: a prospective one-season follow-up [published online ahead of print May 9, 2007]. Scand J Med Sci Sports. 2008;18:49-54.
12. New world record. Floorball Central Web site. http://www.floorballcentral.com/2010/11/new-world -record.html. Published November 5, 2010. Accessed April 8, 2015.
13. Izumi AK. Letter: pigmented palmar petechiae (black palm). Arch Dermatol. 1974;109:261.
14. Rayan GM. Archery-related injuries of the hand, forearm, and elbow. South Med J. 1992;85:961-964.
1. Aguayo-Leiva I, Vano-Galvan S, Arrazola JM. A purpuric rash. Aust Fam Physician. 2009;38:889-890.
2. Ramelet AA. Exercise-induced vasculitis. J Eur Acad Dermatol Venereol. 2006;20:423-427.
3. Leonard JC, Rieger M. Idiopathic thrombocytopenic purpura presenting in a high school football player: a case report. J Athl Train. 1998;33:269-270.
4. Nordlind K, Bondesson L, Johansson SG, et al. Purpura provoked by cold exposure in a skier. Dermatologica. 1983;167:101-103.
5. Latenser BA, Hempstead RW. Exercise-associated solar purpura in an atypical location. Cutis. 1985;35:365-366.
6. Allan SJ, Humphreys F, Buxton PK. Annular purpura and step aerobics. Clin Exp Dermatol. 1994;19:418.
7. Scott MJ Jr, Scott MJ 3rd. Ping pong patches. Cutis. 1989;43:363-364.
8. Aboutalebi S, Stetson CL. Paintball purpura. J Am Acad Dermatol. 2005;53:901-902.
9. Levsky ME, Crowe M. What is your diagnosis? paintball purpura. Cutis. 2005;75:148, 157-158.
10. Barazi H, Adams BB. Sports purpura. Int J Dermatol. 2006;45:1443.
11. Pasanen K, Parkkari J, Kannus P, et al. Injury risk in female floorball: a prospective one-season follow-up [published online ahead of print May 9, 2007]. Scand J Med Sci Sports. 2008;18:49-54.
12. New world record. Floorball Central Web site. http://www.floorballcentral.com/2010/11/new-world -record.html. Published November 5, 2010. Accessed April 8, 2015.
13. Izumi AK. Letter: pigmented palmar petechiae (black palm). Arch Dermatol. 1974;109:261.
14. Rayan GM. Archery-related injuries of the hand, forearm, and elbow. South Med J. 1992;85:961-964.
In Vivo Confocal Microscopy in the Diagnosis of Onychomycosis
To the Editor:
Onychomycosis is a common nail disease that frequently is caused by dermatophytes and is diagnosed by direct microscopy. Conventional diagnostic methods are often time consuming and can produce false-positive or false-negative results. We report a case of onychomycosis diagnosed by confocal microscopy and confirmed with routine potassium hydroxide (KOH) examination and fungal culture. Confocal microscopy is a reliable, practical, and noninvasive technique in the diagnosis of onychomycosis.
A 46-year-old woman presented with yellow-brown discoloration and dystrophy of the toenails (Figure 1) that had become worse over a 5-year period. She was otherwise healthy and had no other dermatologic problems. Examination revealed yellow-brown discoloration, subungual hyperkeratosis, and onycholysis of the toenails. Clinically, a diagnosis of onychomycosis was made. Potassium hydroxide examination of a scraping from the subungual region showed fungal elements. Trichophyton rubrum on Sabouraud dextrose agar was determined.
|
We performed both in vivo and in vitro confocal laser scanning microscopic examination of the nail of the right great toe (Figure 2). For the diagnosis of onychomycosis in our case, we used a multilaser reflectance confocal microscope (RCM) with a wavelength of 786 nm. In vivo confocal microscopy of the nail revealed branching hyphae just below the surface of the nail plate. Hyphae were seen as refractile, bright, linear structures along the laminates of the nail.
Onychomycosis is a common condition affecting 5.5% of the population worldwide and representing 20% to 40% of all onychopathies and approximately 30% of cutaneous mycotic infections.1,2 There are many methods available to confirm the clinical diagnosis of onychomycosis by detecting the causative organisms. Direct microscopic examination of the scraping with a KOH culture, histopathologic assessment with periodic acid–Schiff staining, immunofluorescence analysis with calcofluor white staining, enzyme analysis, and polymerase chain reaction can be used for diagnosis of fungal infections. The most frequently used diagnostic method for onychomycosis is KOH examination of the scraping; however, fungal culture and histopathologic examination also can be used in cases having diagnostic difficulties.1,3,4 There are many studies comparing the efficacies of these methods in the literature.5-9
The causative fungal agent should be determined with at least 1 laboratory method due to the high cost, long duration, and serious potential adverse effects of systemic antifungal treatment. Direct microscopic examination with KOH in the diagnosis of onychomycosis is simple, fast, and inexpensive. However, inadequate material, using crystallized KOH for hydrolysis, insufficient or too much hydrolysis of scrapings, inappropriate staining, and not scanning all areas in the microscopy produce false-negative results. Similarly, secondary contamination of hair, cotton, yarn, or air bubbles mimicking fungal structures can cause false-positive results.9,10
Fungal culture is another diagnostic method that is accepted as the gold standard for diagnosis of onychomycosis.9 However, fungal cultures were positive in only 43% to 50% of all cases of onychomycosis that were diagnosed with other methods,11,12 which may be due to the loss of viability and ability of the fungi to grow in culture media during the transport. A major advantage of fungal culture is that the fungal agent can be classified as dermatophyte, nondermatophyte, mold, or yeast. However, culture does determine if the growing fungi is contamination or the real pathogen. Moreover, it is necessary to wait 3 to 4 weeks for culture results. For nondermatophyte fungi this time may be much longer.12
In vivo RCM is a noninvasive imaging method that allows optical en face sectioning of the living tissue with high resolution. Currently, RCM has a wide range of applications, such as the evaluation of both benign and malignant skin lesions in clinical dermatology.13
In vivo RCM was used first by Hongcharu et al.14 The diagnoses of onychomycosis and fungal hyphae were shown both in vivo and in vitro.14 The sensitivity and specificity of confocal examination in the diagnosis of onychomycosis is not known yet. Large clinical trials are needed to assess the sensitivity and specificity of this method in diagnosing fungal infections.
Onychomycosis is a contagious infectious disease characterized by hyphae proliferation in the nail plate. Definitive diagnosis is necessary before treatment because onychomycosis can be mistaken for many infectious or noninfectious skin diseases with nail involvement. Conventional methods are time consuming, laborious, and less reliable. Instead of high-cost procedures, in vivo confocal microscopic examination can be a rapid and reliable diagnostic method for onychomycosis in the near future.
1. Singal A, Khanna D. Onychomycosis: diagnosis and management. Indian J Dermatol Venereol Leprol. 2011;77:659-672.
2. Kaur R, Kashyap B, Bhalla P. Onychomycosis—epidemiology, diagnosis and management. Indian J Med Microbiol. 2008;26:108-116.
3. Richardson MD. Diagnosis and pathogenesis of dermatophyte infections. Br J Clin Pract Suppl. 1990;71:98-102.
4. Jensen RH, Arendrup MC. Molecular diagnosis of dermato-phyte infections. Curr Opin Infect Dis. 2012;25:126-134.
5. Weinberg JM, Koestenblatt EK, Tutrone WD, et al. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol. 2003;49:193-197.
6. Gianni C, Morelli V, Cerri A, et al. Usefulness of histological examination for the diagnosis of onychomycosis. Dermatology. 2001;202:283-288.
7. Machler BC, Kirsner RS, Elgart GW. Routine histologic examination for the diagnosis of onychomycosis: an evaluation of sensitivity and specificity. Cutis. 1998;61:217-219.
8. Wilsmann-Theis D, Sareika F, Bieber T, et al. New reasons for histopathological nail-clipping examination in the diagnosis of onychomycosis. J Eur Acad Dermatol Venereol. 2011;25:235-237.
9. Reisberger EM, Abels C, Landthaler M, et al. Histopathological diagnosis of onychomycosis by periodic acid-Schiff-stained nail clippings. Br J Dermatol. 2003;148:749-754.
10. Shemer A, Trau H, Davidovici B, et al. Collection of fungi samples from nails: comparative study of curettage and drilling techniques. J Eur Acad Dermatol Venereol. 2008;22:182-185.
11. Daniel CR 3rd, Elewski BE. The diagnosis of nail fungus infection revisited. Arch Dermatol. 2000;136:1162-1164.
12. Borkowski P, Williams M, Holewinski J, et al. Onychomycosis: an analysis of 50 cases and a comparison of diagnostic techniques. J Am Podiatr Med Assoc. 2001;91:351-355.
13. Rajadhyaksha M, Gonzalez S, Zavislan JM, et al. In vivo confocal scanning laser microscopy of human skin II: advances in instrumentation and comparison with histology. J Invest Dermatol. 1999;113:293-303.
14. Hongcharu W, Dwyer P, Gonzalez S, et al. Confirmation of onychomycosis by in vivo confocal microscopy. J Am Acad Dermatol. 2000;42(2, pt 1):214-216.
To the Editor:
Onychomycosis is a common nail disease that frequently is caused by dermatophytes and is diagnosed by direct microscopy. Conventional diagnostic methods are often time consuming and can produce false-positive or false-negative results. We report a case of onychomycosis diagnosed by confocal microscopy and confirmed with routine potassium hydroxide (KOH) examination and fungal culture. Confocal microscopy is a reliable, practical, and noninvasive technique in the diagnosis of onychomycosis.
A 46-year-old woman presented with yellow-brown discoloration and dystrophy of the toenails (Figure 1) that had become worse over a 5-year period. She was otherwise healthy and had no other dermatologic problems. Examination revealed yellow-brown discoloration, subungual hyperkeratosis, and onycholysis of the toenails. Clinically, a diagnosis of onychomycosis was made. Potassium hydroxide examination of a scraping from the subungual region showed fungal elements. Trichophyton rubrum on Sabouraud dextrose agar was determined.
|
We performed both in vivo and in vitro confocal laser scanning microscopic examination of the nail of the right great toe (Figure 2). For the diagnosis of onychomycosis in our case, we used a multilaser reflectance confocal microscope (RCM) with a wavelength of 786 nm. In vivo confocal microscopy of the nail revealed branching hyphae just below the surface of the nail plate. Hyphae were seen as refractile, bright, linear structures along the laminates of the nail.
Onychomycosis is a common condition affecting 5.5% of the population worldwide and representing 20% to 40% of all onychopathies and approximately 30% of cutaneous mycotic infections.1,2 There are many methods available to confirm the clinical diagnosis of onychomycosis by detecting the causative organisms. Direct microscopic examination of the scraping with a KOH culture, histopathologic assessment with periodic acid–Schiff staining, immunofluorescence analysis with calcofluor white staining, enzyme analysis, and polymerase chain reaction can be used for diagnosis of fungal infections. The most frequently used diagnostic method for onychomycosis is KOH examination of the scraping; however, fungal culture and histopathologic examination also can be used in cases having diagnostic difficulties.1,3,4 There are many studies comparing the efficacies of these methods in the literature.5-9
The causative fungal agent should be determined with at least 1 laboratory method due to the high cost, long duration, and serious potential adverse effects of systemic antifungal treatment. Direct microscopic examination with KOH in the diagnosis of onychomycosis is simple, fast, and inexpensive. However, inadequate material, using crystallized KOH for hydrolysis, insufficient or too much hydrolysis of scrapings, inappropriate staining, and not scanning all areas in the microscopy produce false-negative results. Similarly, secondary contamination of hair, cotton, yarn, or air bubbles mimicking fungal structures can cause false-positive results.9,10
Fungal culture is another diagnostic method that is accepted as the gold standard for diagnosis of onychomycosis.9 However, fungal cultures were positive in only 43% to 50% of all cases of onychomycosis that were diagnosed with other methods,11,12 which may be due to the loss of viability and ability of the fungi to grow in culture media during the transport. A major advantage of fungal culture is that the fungal agent can be classified as dermatophyte, nondermatophyte, mold, or yeast. However, culture does determine if the growing fungi is contamination or the real pathogen. Moreover, it is necessary to wait 3 to 4 weeks for culture results. For nondermatophyte fungi this time may be much longer.12
In vivo RCM is a noninvasive imaging method that allows optical en face sectioning of the living tissue with high resolution. Currently, RCM has a wide range of applications, such as the evaluation of both benign and malignant skin lesions in clinical dermatology.13
In vivo RCM was used first by Hongcharu et al.14 The diagnoses of onychomycosis and fungal hyphae were shown both in vivo and in vitro.14 The sensitivity and specificity of confocal examination in the diagnosis of onychomycosis is not known yet. Large clinical trials are needed to assess the sensitivity and specificity of this method in diagnosing fungal infections.
Onychomycosis is a contagious infectious disease characterized by hyphae proliferation in the nail plate. Definitive diagnosis is necessary before treatment because onychomycosis can be mistaken for many infectious or noninfectious skin diseases with nail involvement. Conventional methods are time consuming, laborious, and less reliable. Instead of high-cost procedures, in vivo confocal microscopic examination can be a rapid and reliable diagnostic method for onychomycosis in the near future.
To the Editor:
Onychomycosis is a common nail disease that frequently is caused by dermatophytes and is diagnosed by direct microscopy. Conventional diagnostic methods are often time consuming and can produce false-positive or false-negative results. We report a case of onychomycosis diagnosed by confocal microscopy and confirmed with routine potassium hydroxide (KOH) examination and fungal culture. Confocal microscopy is a reliable, practical, and noninvasive technique in the diagnosis of onychomycosis.
A 46-year-old woman presented with yellow-brown discoloration and dystrophy of the toenails (Figure 1) that had become worse over a 5-year period. She was otherwise healthy and had no other dermatologic problems. Examination revealed yellow-brown discoloration, subungual hyperkeratosis, and onycholysis of the toenails. Clinically, a diagnosis of onychomycosis was made. Potassium hydroxide examination of a scraping from the subungual region showed fungal elements. Trichophyton rubrum on Sabouraud dextrose agar was determined.
|
We performed both in vivo and in vitro confocal laser scanning microscopic examination of the nail of the right great toe (Figure 2). For the diagnosis of onychomycosis in our case, we used a multilaser reflectance confocal microscope (RCM) with a wavelength of 786 nm. In vivo confocal microscopy of the nail revealed branching hyphae just below the surface of the nail plate. Hyphae were seen as refractile, bright, linear structures along the laminates of the nail.
Onychomycosis is a common condition affecting 5.5% of the population worldwide and representing 20% to 40% of all onychopathies and approximately 30% of cutaneous mycotic infections.1,2 There are many methods available to confirm the clinical diagnosis of onychomycosis by detecting the causative organisms. Direct microscopic examination of the scraping with a KOH culture, histopathologic assessment with periodic acid–Schiff staining, immunofluorescence analysis with calcofluor white staining, enzyme analysis, and polymerase chain reaction can be used for diagnosis of fungal infections. The most frequently used diagnostic method for onychomycosis is KOH examination of the scraping; however, fungal culture and histopathologic examination also can be used in cases having diagnostic difficulties.1,3,4 There are many studies comparing the efficacies of these methods in the literature.5-9
The causative fungal agent should be determined with at least 1 laboratory method due to the high cost, long duration, and serious potential adverse effects of systemic antifungal treatment. Direct microscopic examination with KOH in the diagnosis of onychomycosis is simple, fast, and inexpensive. However, inadequate material, using crystallized KOH for hydrolysis, insufficient or too much hydrolysis of scrapings, inappropriate staining, and not scanning all areas in the microscopy produce false-negative results. Similarly, secondary contamination of hair, cotton, yarn, or air bubbles mimicking fungal structures can cause false-positive results.9,10
Fungal culture is another diagnostic method that is accepted as the gold standard for diagnosis of onychomycosis.9 However, fungal cultures were positive in only 43% to 50% of all cases of onychomycosis that were diagnosed with other methods,11,12 which may be due to the loss of viability and ability of the fungi to grow in culture media during the transport. A major advantage of fungal culture is that the fungal agent can be classified as dermatophyte, nondermatophyte, mold, or yeast. However, culture does determine if the growing fungi is contamination or the real pathogen. Moreover, it is necessary to wait 3 to 4 weeks for culture results. For nondermatophyte fungi this time may be much longer.12
In vivo RCM is a noninvasive imaging method that allows optical en face sectioning of the living tissue with high resolution. Currently, RCM has a wide range of applications, such as the evaluation of both benign and malignant skin lesions in clinical dermatology.13
In vivo RCM was used first by Hongcharu et al.14 The diagnoses of onychomycosis and fungal hyphae were shown both in vivo and in vitro.14 The sensitivity and specificity of confocal examination in the diagnosis of onychomycosis is not known yet. Large clinical trials are needed to assess the sensitivity and specificity of this method in diagnosing fungal infections.
Onychomycosis is a contagious infectious disease characterized by hyphae proliferation in the nail plate. Definitive diagnosis is necessary before treatment because onychomycosis can be mistaken for many infectious or noninfectious skin diseases with nail involvement. Conventional methods are time consuming, laborious, and less reliable. Instead of high-cost procedures, in vivo confocal microscopic examination can be a rapid and reliable diagnostic method for onychomycosis in the near future.
1. Singal A, Khanna D. Onychomycosis: diagnosis and management. Indian J Dermatol Venereol Leprol. 2011;77:659-672.
2. Kaur R, Kashyap B, Bhalla P. Onychomycosis—epidemiology, diagnosis and management. Indian J Med Microbiol. 2008;26:108-116.
3. Richardson MD. Diagnosis and pathogenesis of dermatophyte infections. Br J Clin Pract Suppl. 1990;71:98-102.
4. Jensen RH, Arendrup MC. Molecular diagnosis of dermato-phyte infections. Curr Opin Infect Dis. 2012;25:126-134.
5. Weinberg JM, Koestenblatt EK, Tutrone WD, et al. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol. 2003;49:193-197.
6. Gianni C, Morelli V, Cerri A, et al. Usefulness of histological examination for the diagnosis of onychomycosis. Dermatology. 2001;202:283-288.
7. Machler BC, Kirsner RS, Elgart GW. Routine histologic examination for the diagnosis of onychomycosis: an evaluation of sensitivity and specificity. Cutis. 1998;61:217-219.
8. Wilsmann-Theis D, Sareika F, Bieber T, et al. New reasons for histopathological nail-clipping examination in the diagnosis of onychomycosis. J Eur Acad Dermatol Venereol. 2011;25:235-237.
9. Reisberger EM, Abels C, Landthaler M, et al. Histopathological diagnosis of onychomycosis by periodic acid-Schiff-stained nail clippings. Br J Dermatol. 2003;148:749-754.
10. Shemer A, Trau H, Davidovici B, et al. Collection of fungi samples from nails: comparative study of curettage and drilling techniques. J Eur Acad Dermatol Venereol. 2008;22:182-185.
11. Daniel CR 3rd, Elewski BE. The diagnosis of nail fungus infection revisited. Arch Dermatol. 2000;136:1162-1164.
12. Borkowski P, Williams M, Holewinski J, et al. Onychomycosis: an analysis of 50 cases and a comparison of diagnostic techniques. J Am Podiatr Med Assoc. 2001;91:351-355.
13. Rajadhyaksha M, Gonzalez S, Zavislan JM, et al. In vivo confocal scanning laser microscopy of human skin II: advances in instrumentation and comparison with histology. J Invest Dermatol. 1999;113:293-303.
14. Hongcharu W, Dwyer P, Gonzalez S, et al. Confirmation of onychomycosis by in vivo confocal microscopy. J Am Acad Dermatol. 2000;42(2, pt 1):214-216.
1. Singal A, Khanna D. Onychomycosis: diagnosis and management. Indian J Dermatol Venereol Leprol. 2011;77:659-672.
2. Kaur R, Kashyap B, Bhalla P. Onychomycosis—epidemiology, diagnosis and management. Indian J Med Microbiol. 2008;26:108-116.
3. Richardson MD. Diagnosis and pathogenesis of dermatophyte infections. Br J Clin Pract Suppl. 1990;71:98-102.
4. Jensen RH, Arendrup MC. Molecular diagnosis of dermato-phyte infections. Curr Opin Infect Dis. 2012;25:126-134.
5. Weinberg JM, Koestenblatt EK, Tutrone WD, et al. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol. 2003;49:193-197.
6. Gianni C, Morelli V, Cerri A, et al. Usefulness of histological examination for the diagnosis of onychomycosis. Dermatology. 2001;202:283-288.
7. Machler BC, Kirsner RS, Elgart GW. Routine histologic examination for the diagnosis of onychomycosis: an evaluation of sensitivity and specificity. Cutis. 1998;61:217-219.
8. Wilsmann-Theis D, Sareika F, Bieber T, et al. New reasons for histopathological nail-clipping examination in the diagnosis of onychomycosis. J Eur Acad Dermatol Venereol. 2011;25:235-237.
9. Reisberger EM, Abels C, Landthaler M, et al. Histopathological diagnosis of onychomycosis by periodic acid-Schiff-stained nail clippings. Br J Dermatol. 2003;148:749-754.
10. Shemer A, Trau H, Davidovici B, et al. Collection of fungi samples from nails: comparative study of curettage and drilling techniques. J Eur Acad Dermatol Venereol. 2008;22:182-185.
11. Daniel CR 3rd, Elewski BE. The diagnosis of nail fungus infection revisited. Arch Dermatol. 2000;136:1162-1164.
12. Borkowski P, Williams M, Holewinski J, et al. Onychomycosis: an analysis of 50 cases and a comparison of diagnostic techniques. J Am Podiatr Med Assoc. 2001;91:351-355.
13. Rajadhyaksha M, Gonzalez S, Zavislan JM, et al. In vivo confocal scanning laser microscopy of human skin II: advances in instrumentation and comparison with histology. J Invest Dermatol. 1999;113:293-303.
14. Hongcharu W, Dwyer P, Gonzalez S, et al. Confirmation of onychomycosis by in vivo confocal microscopy. J Am Acad Dermatol. 2000;42(2, pt 1):214-216.
Pneumonic Tularemia Presenting With a Vesicular Eruption
To the Editor:
A 38-year-old microbiologist presented to a primary care physician with fevers, night sweats, myalgia, and headaches of 2 weeks’ duration. She was treated for a presumed viral illness with antipyretics and fluids. The patient subsequently developed a persistent nonproductive cough and chest pain as well as painful nodules of the lower legs and a vesicular rash over the trunk and arms. The patient worked closely with Yersinia pestis and Francisella tularensis and because of the occupational exposure had a thorough evaluation. An increased bacterial agglutinin titer for F tularensis from 1:40 to 1:1280 was noted during repeat testing over a 1-week period and a polymerase chain reaction test of sputum was positive for F tularensis. Chest radiography revealed right lower lobe pneumonia and adenopathy. The patient was admitted to the hospital for pneumonic tularemia and was treated with streptomycin with rapid improvement; however, after development of tinnitus and vertigo she was switched to ciprofloxacin.
![]() ![]() |
Dermatology was consulted to evaluate the patient’s nonpruritic vesicular rash that had been present for 6 days. Examination revealed multiple erythematous papules and plaques with vesicles rimming the periphery or studded throughout the lesions (Figures 1 and 2). Tender ecchymotic subcutaneous nodules of the lower extremities consistent with erythema nodosum also were present. Punch biopsies taken from vesicular papules of the back showed superficial perivascular inflammation and vesiculation within the epidermis (Figure 3). Polymerase chain reaction analysis revealed F tularensis. The patient was discharged with continued improvement after completion of the 1-month antibiotic regimen.
Vesicular papules and plaques are uncommon cutaneous manifestations of tularemia with few reports since the first documented cases of vesicular tularemia.1,2 A summary of 654 cases of tularemia in 1928 revealed 1 case with a vesicular rash.3 A retrospective review of 234 cases in Sweden in 2007 noted a vesicular rash in 7 patients (3.0%),4 and 2 subsequent cases of vesicular skin lesions in children with culture-positive tularemia initially were misdiagnosed as herpes simplex virus or varicella-zoster virus.5
Fewer than 200 cases of tularemia are reported to the Centers for Disease Control and Prevention annually, yet outbreaks do occur.5 Tularemia is primarily contracted through contact with infected animals (eg, rabbits) or vector insects (eg, deer flies, Dermacentor ticks). However, the disease remains a concern as a potential bioweapon via inhalation of aerosolized particles. A victim of bioterrorism may present in a manner similar to our patient. Although the threat of bioterrorism and incidence of tularemia in the United States is low, vesicular papules may be a presentation of tularemia and should be considered in the evaluation of a vesicular rash.
![]() ![]() |
1. Pearse R. Insect bites. Northwest Med. 1911;3:81-82.
2. Francis E. The occurrence of tularemia in nature as a disease of man. Pub Health Rep. 1921;36:1731-1746.
3. Francis E. A summary of present knowledge of tularemia. Medicine. 1928;7:411-432.
4. Eliasson H, Bäck E. Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years. Scand J Infect Dis. 2007;39:880-889.
5. Byington C, Bender J, Ampofo K, et al. Tularemia with vesicular skin lesions may be mistaken for infection with herpes viruses. Clin Infect Dis. 2008;47:e4-e6.
To the Editor:
A 38-year-old microbiologist presented to a primary care physician with fevers, night sweats, myalgia, and headaches of 2 weeks’ duration. She was treated for a presumed viral illness with antipyretics and fluids. The patient subsequently developed a persistent nonproductive cough and chest pain as well as painful nodules of the lower legs and a vesicular rash over the trunk and arms. The patient worked closely with Yersinia pestis and Francisella tularensis and because of the occupational exposure had a thorough evaluation. An increased bacterial agglutinin titer for F tularensis from 1:40 to 1:1280 was noted during repeat testing over a 1-week period and a polymerase chain reaction test of sputum was positive for F tularensis. Chest radiography revealed right lower lobe pneumonia and adenopathy. The patient was admitted to the hospital for pneumonic tularemia and was treated with streptomycin with rapid improvement; however, after development of tinnitus and vertigo she was switched to ciprofloxacin.
![]() ![]() |
Dermatology was consulted to evaluate the patient’s nonpruritic vesicular rash that had been present for 6 days. Examination revealed multiple erythematous papules and plaques with vesicles rimming the periphery or studded throughout the lesions (Figures 1 and 2). Tender ecchymotic subcutaneous nodules of the lower extremities consistent with erythema nodosum also were present. Punch biopsies taken from vesicular papules of the back showed superficial perivascular inflammation and vesiculation within the epidermis (Figure 3). Polymerase chain reaction analysis revealed F tularensis. The patient was discharged with continued improvement after completion of the 1-month antibiotic regimen.
Vesicular papules and plaques are uncommon cutaneous manifestations of tularemia with few reports since the first documented cases of vesicular tularemia.1,2 A summary of 654 cases of tularemia in 1928 revealed 1 case with a vesicular rash.3 A retrospective review of 234 cases in Sweden in 2007 noted a vesicular rash in 7 patients (3.0%),4 and 2 subsequent cases of vesicular skin lesions in children with culture-positive tularemia initially were misdiagnosed as herpes simplex virus or varicella-zoster virus.5
Fewer than 200 cases of tularemia are reported to the Centers for Disease Control and Prevention annually, yet outbreaks do occur.5 Tularemia is primarily contracted through contact with infected animals (eg, rabbits) or vector insects (eg, deer flies, Dermacentor ticks). However, the disease remains a concern as a potential bioweapon via inhalation of aerosolized particles. A victim of bioterrorism may present in a manner similar to our patient. Although the threat of bioterrorism and incidence of tularemia in the United States is low, vesicular papules may be a presentation of tularemia and should be considered in the evaluation of a vesicular rash.
![]() ![]() |
To the Editor:
A 38-year-old microbiologist presented to a primary care physician with fevers, night sweats, myalgia, and headaches of 2 weeks’ duration. She was treated for a presumed viral illness with antipyretics and fluids. The patient subsequently developed a persistent nonproductive cough and chest pain as well as painful nodules of the lower legs and a vesicular rash over the trunk and arms. The patient worked closely with Yersinia pestis and Francisella tularensis and because of the occupational exposure had a thorough evaluation. An increased bacterial agglutinin titer for F tularensis from 1:40 to 1:1280 was noted during repeat testing over a 1-week period and a polymerase chain reaction test of sputum was positive for F tularensis. Chest radiography revealed right lower lobe pneumonia and adenopathy. The patient was admitted to the hospital for pneumonic tularemia and was treated with streptomycin with rapid improvement; however, after development of tinnitus and vertigo she was switched to ciprofloxacin.
![]() ![]() |
Dermatology was consulted to evaluate the patient’s nonpruritic vesicular rash that had been present for 6 days. Examination revealed multiple erythematous papules and plaques with vesicles rimming the periphery or studded throughout the lesions (Figures 1 and 2). Tender ecchymotic subcutaneous nodules of the lower extremities consistent with erythema nodosum also were present. Punch biopsies taken from vesicular papules of the back showed superficial perivascular inflammation and vesiculation within the epidermis (Figure 3). Polymerase chain reaction analysis revealed F tularensis. The patient was discharged with continued improvement after completion of the 1-month antibiotic regimen.
Vesicular papules and plaques are uncommon cutaneous manifestations of tularemia with few reports since the first documented cases of vesicular tularemia.1,2 A summary of 654 cases of tularemia in 1928 revealed 1 case with a vesicular rash.3 A retrospective review of 234 cases in Sweden in 2007 noted a vesicular rash in 7 patients (3.0%),4 and 2 subsequent cases of vesicular skin lesions in children with culture-positive tularemia initially were misdiagnosed as herpes simplex virus or varicella-zoster virus.5
Fewer than 200 cases of tularemia are reported to the Centers for Disease Control and Prevention annually, yet outbreaks do occur.5 Tularemia is primarily contracted through contact with infected animals (eg, rabbits) or vector insects (eg, deer flies, Dermacentor ticks). However, the disease remains a concern as a potential bioweapon via inhalation of aerosolized particles. A victim of bioterrorism may present in a manner similar to our patient. Although the threat of bioterrorism and incidence of tularemia in the United States is low, vesicular papules may be a presentation of tularemia and should be considered in the evaluation of a vesicular rash.
![]() ![]() |
1. Pearse R. Insect bites. Northwest Med. 1911;3:81-82.
2. Francis E. The occurrence of tularemia in nature as a disease of man. Pub Health Rep. 1921;36:1731-1746.
3. Francis E. A summary of present knowledge of tularemia. Medicine. 1928;7:411-432.
4. Eliasson H, Bäck E. Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years. Scand J Infect Dis. 2007;39:880-889.
5. Byington C, Bender J, Ampofo K, et al. Tularemia with vesicular skin lesions may be mistaken for infection with herpes viruses. Clin Infect Dis. 2008;47:e4-e6.
1. Pearse R. Insect bites. Northwest Med. 1911;3:81-82.
2. Francis E. The occurrence of tularemia in nature as a disease of man. Pub Health Rep. 1921;36:1731-1746.
3. Francis E. A summary of present knowledge of tularemia. Medicine. 1928;7:411-432.
4. Eliasson H, Bäck E. Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years. Scand J Infect Dis. 2007;39:880-889.
5. Byington C, Bender J, Ampofo K, et al. Tularemia with vesicular skin lesions may be mistaken for infection with herpes viruses. Clin Infect Dis. 2008;47:e4-e6.
Rapidly Recurring Keratoacanthoma
To the Editor:
A 61-year-old man with a medical history of type 2 diabetes mellitus presented to us with a 2.5×3.0-cm erythematous, ulcerated, and exophytic tumor on the right dorsal forearm that had rapidly developed over 2 weeks. A tangential biopsy was performed followed by treatment with electrodesiccation and curettage (ED&C). Histology revealed a squamous cell carcinoma (SCC), keratoacanthoma (KA) type. Over the next 11 days the lesion rapidly recurred and the patient returned with his own daily photodocumentation of the KA’s progression (Figure). The lesion was re-excised with 5-mm margins; histology again revealed SCC, KA type, with deep margin involvement. Chest radiograph revealed findings suspicious for metastatic lesions in the right lung. He was referred to oncology for metastatic workup; positron emission tomography was negative and ultimately the lung lesion was found to be benign. The patient underwent adjuvant radia-tion to the KA resection bed and lymph nodes with minimal side effects. The patient has remained cancer free to date.
Keratoacanthomas are rapidly growing, typically painless, cutaneous neoplasms that often develop on sun-exposed areas. They can occur spontaneously or following trauma and have the propensity to regress with time.1-3 They are described as progressing through 3 clinical stages: rapid proliferation, mature/stable, and involution. However, KAs can be aggressive, becoming locally destructive; therefore, KAs are typically treated to avoid further morbidity. Keratoacanthomas may be considered a subtype of SCC, as some have the potential to become locally destructive and metastasize.3-5 There are reports of spontaneous resolution of KAs over weeks to months, though surgical excision is the gold standard of treatment.3,5
Reactive KA is a subtype that is thought to develop at the site of prior trauma, representing a sort of Köbner phenomenon.3,4 We demonstrated a case of a recurrent KA in the setting of recent ED&C. Several reports describe KAs developing after dermatologic surgery, including Mohs micrographic surgery, laser resurfacing, radiation therapy, and after skin grafting.3,4,6 Trauma-induced epidermal injury and dermal inflammation may play a role in postoperative KA formation or recurrence.6
Keratoacanthoma recurrence has been reported in 3% to 8% of cases within a few weeks after treatment, as seen in our current patient.3,5 In our case, the patient photodocumented the regrowth of his lesion (Figure). Treatment of reactive KAs may be therapeutically challenging, as they can form or worsen with repeated surgeries and may require several treatment modalities to eradicate them.4 Treatment options include observation, ED&C, excision, Mohs micrographic surgery, radiation, cryosurgery, laser, isotretinoin, acitretin, imiquimod, 5-fluorouracil, methotrexate, interferon alfa-2b, or bleomycin, to name a few.3,4,7
Combination therapy should be considered in the presence of recurrent and/or aggressive KAs, such as in our case. Our patient has remained disease free after a combination of surgical excision with radiation therapy.
1. Schwartz R. Keratoacanthoma. J Am Acad Dermatol. 1994;30:1-19.
2. Kingman J. Keratoacanthoma. Arch Dermatol. 1984;20:736-740.
3. Goldberg L, Silapunt S, Beyrau K, et al. Keratoacanthoma as a postoperative complication of skin cancer excision. J Am Acad Dermatol. 2004;50:753-758.
4. Hadley J, Tristani-Firouzi P, Florell S, et al. Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins. Dermatol Surg. 2009;35:2019-2024.
5. Karaa A, Khachemoune A. Keratoacanthoma: a tumor in search of a classification. Int J Dermatol. 2007;46:671-678.
6. Chesnut GT, Maggio KL, Turiansky GW. Letter: re: case series of multiple recurrent reactive keratoacanthomas developing at surgical margins. Dermatol Surg. 2011;37:884-885.
7. Lernia V, Ricci C, Albertini G. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream. J Eur Acad Dermatol Venereol. 2004;18:626-629.
To the Editor:
A 61-year-old man with a medical history of type 2 diabetes mellitus presented to us with a 2.5×3.0-cm erythematous, ulcerated, and exophytic tumor on the right dorsal forearm that had rapidly developed over 2 weeks. A tangential biopsy was performed followed by treatment with electrodesiccation and curettage (ED&C). Histology revealed a squamous cell carcinoma (SCC), keratoacanthoma (KA) type. Over the next 11 days the lesion rapidly recurred and the patient returned with his own daily photodocumentation of the KA’s progression (Figure). The lesion was re-excised with 5-mm margins; histology again revealed SCC, KA type, with deep margin involvement. Chest radiograph revealed findings suspicious for metastatic lesions in the right lung. He was referred to oncology for metastatic workup; positron emission tomography was negative and ultimately the lung lesion was found to be benign. The patient underwent adjuvant radia-tion to the KA resection bed and lymph nodes with minimal side effects. The patient has remained cancer free to date.
Keratoacanthomas are rapidly growing, typically painless, cutaneous neoplasms that often develop on sun-exposed areas. They can occur spontaneously or following trauma and have the propensity to regress with time.1-3 They are described as progressing through 3 clinical stages: rapid proliferation, mature/stable, and involution. However, KAs can be aggressive, becoming locally destructive; therefore, KAs are typically treated to avoid further morbidity. Keratoacanthomas may be considered a subtype of SCC, as some have the potential to become locally destructive and metastasize.3-5 There are reports of spontaneous resolution of KAs over weeks to months, though surgical excision is the gold standard of treatment.3,5
Reactive KA is a subtype that is thought to develop at the site of prior trauma, representing a sort of Köbner phenomenon.3,4 We demonstrated a case of a recurrent KA in the setting of recent ED&C. Several reports describe KAs developing after dermatologic surgery, including Mohs micrographic surgery, laser resurfacing, radiation therapy, and after skin grafting.3,4,6 Trauma-induced epidermal injury and dermal inflammation may play a role in postoperative KA formation or recurrence.6
Keratoacanthoma recurrence has been reported in 3% to 8% of cases within a few weeks after treatment, as seen in our current patient.3,5 In our case, the patient photodocumented the regrowth of his lesion (Figure). Treatment of reactive KAs may be therapeutically challenging, as they can form or worsen with repeated surgeries and may require several treatment modalities to eradicate them.4 Treatment options include observation, ED&C, excision, Mohs micrographic surgery, radiation, cryosurgery, laser, isotretinoin, acitretin, imiquimod, 5-fluorouracil, methotrexate, interferon alfa-2b, or bleomycin, to name a few.3,4,7
Combination therapy should be considered in the presence of recurrent and/or aggressive KAs, such as in our case. Our patient has remained disease free after a combination of surgical excision with radiation therapy.
To the Editor:
A 61-year-old man with a medical history of type 2 diabetes mellitus presented to us with a 2.5×3.0-cm erythematous, ulcerated, and exophytic tumor on the right dorsal forearm that had rapidly developed over 2 weeks. A tangential biopsy was performed followed by treatment with electrodesiccation and curettage (ED&C). Histology revealed a squamous cell carcinoma (SCC), keratoacanthoma (KA) type. Over the next 11 days the lesion rapidly recurred and the patient returned with his own daily photodocumentation of the KA’s progression (Figure). The lesion was re-excised with 5-mm margins; histology again revealed SCC, KA type, with deep margin involvement. Chest radiograph revealed findings suspicious for metastatic lesions in the right lung. He was referred to oncology for metastatic workup; positron emission tomography was negative and ultimately the lung lesion was found to be benign. The patient underwent adjuvant radia-tion to the KA resection bed and lymph nodes with minimal side effects. The patient has remained cancer free to date.
Keratoacanthomas are rapidly growing, typically painless, cutaneous neoplasms that often develop on sun-exposed areas. They can occur spontaneously or following trauma and have the propensity to regress with time.1-3 They are described as progressing through 3 clinical stages: rapid proliferation, mature/stable, and involution. However, KAs can be aggressive, becoming locally destructive; therefore, KAs are typically treated to avoid further morbidity. Keratoacanthomas may be considered a subtype of SCC, as some have the potential to become locally destructive and metastasize.3-5 There are reports of spontaneous resolution of KAs over weeks to months, though surgical excision is the gold standard of treatment.3,5
Reactive KA is a subtype that is thought to develop at the site of prior trauma, representing a sort of Köbner phenomenon.3,4 We demonstrated a case of a recurrent KA in the setting of recent ED&C. Several reports describe KAs developing after dermatologic surgery, including Mohs micrographic surgery, laser resurfacing, radiation therapy, and after skin grafting.3,4,6 Trauma-induced epidermal injury and dermal inflammation may play a role in postoperative KA formation or recurrence.6
Keratoacanthoma recurrence has been reported in 3% to 8% of cases within a few weeks after treatment, as seen in our current patient.3,5 In our case, the patient photodocumented the regrowth of his lesion (Figure). Treatment of reactive KAs may be therapeutically challenging, as they can form or worsen with repeated surgeries and may require several treatment modalities to eradicate them.4 Treatment options include observation, ED&C, excision, Mohs micrographic surgery, radiation, cryosurgery, laser, isotretinoin, acitretin, imiquimod, 5-fluorouracil, methotrexate, interferon alfa-2b, or bleomycin, to name a few.3,4,7
Combination therapy should be considered in the presence of recurrent and/or aggressive KAs, such as in our case. Our patient has remained disease free after a combination of surgical excision with radiation therapy.
1. Schwartz R. Keratoacanthoma. J Am Acad Dermatol. 1994;30:1-19.
2. Kingman J. Keratoacanthoma. Arch Dermatol. 1984;20:736-740.
3. Goldberg L, Silapunt S, Beyrau K, et al. Keratoacanthoma as a postoperative complication of skin cancer excision. J Am Acad Dermatol. 2004;50:753-758.
4. Hadley J, Tristani-Firouzi P, Florell S, et al. Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins. Dermatol Surg. 2009;35:2019-2024.
5. Karaa A, Khachemoune A. Keratoacanthoma: a tumor in search of a classification. Int J Dermatol. 2007;46:671-678.
6. Chesnut GT, Maggio KL, Turiansky GW. Letter: re: case series of multiple recurrent reactive keratoacanthomas developing at surgical margins. Dermatol Surg. 2011;37:884-885.
7. Lernia V, Ricci C, Albertini G. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream. J Eur Acad Dermatol Venereol. 2004;18:626-629.
1. Schwartz R. Keratoacanthoma. J Am Acad Dermatol. 1994;30:1-19.
2. Kingman J. Keratoacanthoma. Arch Dermatol. 1984;20:736-740.
3. Goldberg L, Silapunt S, Beyrau K, et al. Keratoacanthoma as a postoperative complication of skin cancer excision. J Am Acad Dermatol. 2004;50:753-758.
4. Hadley J, Tristani-Firouzi P, Florell S, et al. Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins. Dermatol Surg. 2009;35:2019-2024.
5. Karaa A, Khachemoune A. Keratoacanthoma: a tumor in search of a classification. Int J Dermatol. 2007;46:671-678.
6. Chesnut GT, Maggio KL, Turiansky GW. Letter: re: case series of multiple recurrent reactive keratoacanthomas developing at surgical margins. Dermatol Surg. 2011;37:884-885.
7. Lernia V, Ricci C, Albertini G. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream. J Eur Acad Dermatol Venereol. 2004;18:626-629.
A Case of Morfan Syndrome
To the Editor:
A 17-year-old adolescent girl presented to our clinic for evaluation of diffuse acanthosis nigricans (AN) that had been present since 7 years of age. The patient had a history of hypothyroidism, insulin resistance, ovarian cysts, and developmental delay. On examination, she presented with thick and verrucous plaques of AN involving the neck, abdomen, trunk, arms, and legs (Figure). The intertriginous areas were affected the most. The examination also was notable for dysmorphic facies and an endomorphic body habitus. Both parents denied similar health problems in their family and were normal in appearance. Although the patient was receiving metformin treatment for insulin resistance, she had not undergone any prior workup to identify a unifying syndromic cause for her physical and biochemical findings. A review of the literature showed a 1993 case report of a 5-year-old boy with mental retardation, body overgrowth, remarkable facies, and AN, which was termed Morfan syndrome.1 Because of the similarity in features, we believe that our patient’s presentation fits this syndrome. This report represents the second documented case of Morfan syndrome according to a PubMed search of articles indexed for MEDLINE using the search term Morfan. Additional searches using the terms acanthosis nigricans and syndrome also failed to identify any reports describing patients with a similar constellation of findings.
|
First described by Santi Unna and Monatsh Pollitzer in 1890, AN is a common dermatosis that is characterized by thick, hyperpigmented, and verrucous plaques.2,3 Although most common in symmetric distribution on flexural and intertriginous areas, AN also may involve mucosal surfaces.4 Acanthosis nigricans is associated with multiple etiologic factors, including direct autosomal transmission, genetic abnormalities, medications, malignancy, and endocrine imbalance.2 However, the diffuse generalized form of AN is almost always found in the context of malignancy or genetic syndromes.5 Historically, most attention on AN has focused on its eruptive form (so-called malignant AN), which is usually associated with internal malignancy but also may result from benign pituitary adenomas.6 Although the precise mechanism for paraneoplastic AN is still a matter of debate, it is likely the result of overactive growth factors, such as transforming growth factor α, epidermal growth factor, and α melanocyte-stimulating hormone.7 Generalized AN also has been associated with genetic abnormalities. Multiple genetic mutations have been associated with AN, including the genes coding for the insulin receptor, fibroblast growth receptors 2 and 3, lamin A/C, and seipin.8-12 Acanthosis nigricans has been described as a feature in other genetic syndromes but may represent an incidental finding.4 In 1976, Kahn et al13 linked AN with insulin resistance, which subsequently shifted the focus on AN’s link with obesity and as a precursor of type 2 diabetes mellitus.6,14 In these cases, it is hypothesized that excess insulin activates the insulinlike growth factor 1 receptor to stimulate keratinocyte and dermal fibroblast proliferation. It is likely that hyperinsulinemia also induces cellular proliferation indirectly through other pathways.15,16 Compared with paraneoplastic and syndromic causes, AN secondary to hyperinsulinemia and obesity does not tend to be generalized but instead is proportionate to the degree of metabolic derangement.17
Because our patient’s AN presentation was diffuse, long-standing, and occurred in the context of morphologic abnormalities, it was consistent with a syndrome. Based on the constellation of findings, we believe our patient fit the rare markers indicating Morfan syndrome. Because of its extreme rarity, there is no specific diagnostic algorithm for Morfan syndrome. As additional cases are reported, we hope that further biochemical, physical, and genetic studies may be pursued to better identify the syndrome and elucidate its pathogenesis.
1. Seemanová E, Rüdiger HW, Dreyer M. Morfan: a new syndrome characterized by mental retardation, pre- and postnatal overgrowth, remarkable face and acanthosis nigricans in 5-year-old boy. Am J Med Genet. 1993;45:525-528.
2. Rendon MI, Cruz PD Jr, Sontheimer RD, et al. Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin. J Am Acad Dermatol. 1989;21:461-469.
3. Unna PG, Morris M, Besnier E, eds. International Atlas of Rare Skin Diseases. London, England: HK Lewis & Co; 1890.
4. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994;31:1-19.
5. Inamdar AC, Palit A. Generalized acanthosis nigricans in childhood. Pediatr Dermatol. 2004;21:277-279.
6. Cruz PD, Hud JA. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J Invest Dermatol. 1992;98:82-85.
7. Krawczyk M, Mykała-Cies´la J, Kołodziej-Jaskuła A. Acanthosis nigricans as a paraneoplastic syndrome. case reports and review of literature. Pol Arch Med Wewn. 2009;119:180-183.
8. Meyers GA, Orlow SJ, Munro IR, et al. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nature Genet. 1995;11:462-464.
9. Moller DE, Cohen O, Yamaguchi Y, et al. Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes. 1994;43:247-255.
10. Przylepa KA, Paznekas W, Zhang M, et al. Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nature Genet. 1996;13:492-494.
11. Anderson JL, Khan M, David WS, et al. Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22. Am J Med Genet. 1992;82:161-165.
12. Simha V, Agarwal AK, Aronin PA, et al. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability. Am J Med Genet. 2008;146A:2318-2326.
13. Kahn CR, Flier JS, Bar RS, et al. the syndromes of insulin resistance and acanthosis nigricans. insulin-receptor disorders in man. N Engl J Med. 1976;294:739-745.
14. Brickman WWJ, Huang J, Silverman BL, et al. Acanthosis nigricans identifies youth at high risk for metabolic abnormalities. J Pediatr. 2010;156:87-92.
15. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. insulin-like growth factors.
N Engl J Med. 1997;336:633-640.
16. Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev. 2001;22:818-835.
17. Berk DR, Spector EB, Bayliss SJ. Familial acanthosis nigricans due to K650T FGFR3 mutation. Arch Dermatol. 2007;143:1153-1156.
To the Editor:
A 17-year-old adolescent girl presented to our clinic for evaluation of diffuse acanthosis nigricans (AN) that had been present since 7 years of age. The patient had a history of hypothyroidism, insulin resistance, ovarian cysts, and developmental delay. On examination, she presented with thick and verrucous plaques of AN involving the neck, abdomen, trunk, arms, and legs (Figure). The intertriginous areas were affected the most. The examination also was notable for dysmorphic facies and an endomorphic body habitus. Both parents denied similar health problems in their family and were normal in appearance. Although the patient was receiving metformin treatment for insulin resistance, she had not undergone any prior workup to identify a unifying syndromic cause for her physical and biochemical findings. A review of the literature showed a 1993 case report of a 5-year-old boy with mental retardation, body overgrowth, remarkable facies, and AN, which was termed Morfan syndrome.1 Because of the similarity in features, we believe that our patient’s presentation fits this syndrome. This report represents the second documented case of Morfan syndrome according to a PubMed search of articles indexed for MEDLINE using the search term Morfan. Additional searches using the terms acanthosis nigricans and syndrome also failed to identify any reports describing patients with a similar constellation of findings.
|
First described by Santi Unna and Monatsh Pollitzer in 1890, AN is a common dermatosis that is characterized by thick, hyperpigmented, and verrucous plaques.2,3 Although most common in symmetric distribution on flexural and intertriginous areas, AN also may involve mucosal surfaces.4 Acanthosis nigricans is associated with multiple etiologic factors, including direct autosomal transmission, genetic abnormalities, medications, malignancy, and endocrine imbalance.2 However, the diffuse generalized form of AN is almost always found in the context of malignancy or genetic syndromes.5 Historically, most attention on AN has focused on its eruptive form (so-called malignant AN), which is usually associated with internal malignancy but also may result from benign pituitary adenomas.6 Although the precise mechanism for paraneoplastic AN is still a matter of debate, it is likely the result of overactive growth factors, such as transforming growth factor α, epidermal growth factor, and α melanocyte-stimulating hormone.7 Generalized AN also has been associated with genetic abnormalities. Multiple genetic mutations have been associated with AN, including the genes coding for the insulin receptor, fibroblast growth receptors 2 and 3, lamin A/C, and seipin.8-12 Acanthosis nigricans has been described as a feature in other genetic syndromes but may represent an incidental finding.4 In 1976, Kahn et al13 linked AN with insulin resistance, which subsequently shifted the focus on AN’s link with obesity and as a precursor of type 2 diabetes mellitus.6,14 In these cases, it is hypothesized that excess insulin activates the insulinlike growth factor 1 receptor to stimulate keratinocyte and dermal fibroblast proliferation. It is likely that hyperinsulinemia also induces cellular proliferation indirectly through other pathways.15,16 Compared with paraneoplastic and syndromic causes, AN secondary to hyperinsulinemia and obesity does not tend to be generalized but instead is proportionate to the degree of metabolic derangement.17
Because our patient’s AN presentation was diffuse, long-standing, and occurred in the context of morphologic abnormalities, it was consistent with a syndrome. Based on the constellation of findings, we believe our patient fit the rare markers indicating Morfan syndrome. Because of its extreme rarity, there is no specific diagnostic algorithm for Morfan syndrome. As additional cases are reported, we hope that further biochemical, physical, and genetic studies may be pursued to better identify the syndrome and elucidate its pathogenesis.
To the Editor:
A 17-year-old adolescent girl presented to our clinic for evaluation of diffuse acanthosis nigricans (AN) that had been present since 7 years of age. The patient had a history of hypothyroidism, insulin resistance, ovarian cysts, and developmental delay. On examination, she presented with thick and verrucous plaques of AN involving the neck, abdomen, trunk, arms, and legs (Figure). The intertriginous areas were affected the most. The examination also was notable for dysmorphic facies and an endomorphic body habitus. Both parents denied similar health problems in their family and were normal in appearance. Although the patient was receiving metformin treatment for insulin resistance, she had not undergone any prior workup to identify a unifying syndromic cause for her physical and biochemical findings. A review of the literature showed a 1993 case report of a 5-year-old boy with mental retardation, body overgrowth, remarkable facies, and AN, which was termed Morfan syndrome.1 Because of the similarity in features, we believe that our patient’s presentation fits this syndrome. This report represents the second documented case of Morfan syndrome according to a PubMed search of articles indexed for MEDLINE using the search term Morfan. Additional searches using the terms acanthosis nigricans and syndrome also failed to identify any reports describing patients with a similar constellation of findings.
|
First described by Santi Unna and Monatsh Pollitzer in 1890, AN is a common dermatosis that is characterized by thick, hyperpigmented, and verrucous plaques.2,3 Although most common in symmetric distribution on flexural and intertriginous areas, AN also may involve mucosal surfaces.4 Acanthosis nigricans is associated with multiple etiologic factors, including direct autosomal transmission, genetic abnormalities, medications, malignancy, and endocrine imbalance.2 However, the diffuse generalized form of AN is almost always found in the context of malignancy or genetic syndromes.5 Historically, most attention on AN has focused on its eruptive form (so-called malignant AN), which is usually associated with internal malignancy but also may result from benign pituitary adenomas.6 Although the precise mechanism for paraneoplastic AN is still a matter of debate, it is likely the result of overactive growth factors, such as transforming growth factor α, epidermal growth factor, and α melanocyte-stimulating hormone.7 Generalized AN also has been associated with genetic abnormalities. Multiple genetic mutations have been associated with AN, including the genes coding for the insulin receptor, fibroblast growth receptors 2 and 3, lamin A/C, and seipin.8-12 Acanthosis nigricans has been described as a feature in other genetic syndromes but may represent an incidental finding.4 In 1976, Kahn et al13 linked AN with insulin resistance, which subsequently shifted the focus on AN’s link with obesity and as a precursor of type 2 diabetes mellitus.6,14 In these cases, it is hypothesized that excess insulin activates the insulinlike growth factor 1 receptor to stimulate keratinocyte and dermal fibroblast proliferation. It is likely that hyperinsulinemia also induces cellular proliferation indirectly through other pathways.15,16 Compared with paraneoplastic and syndromic causes, AN secondary to hyperinsulinemia and obesity does not tend to be generalized but instead is proportionate to the degree of metabolic derangement.17
Because our patient’s AN presentation was diffuse, long-standing, and occurred in the context of morphologic abnormalities, it was consistent with a syndrome. Based on the constellation of findings, we believe our patient fit the rare markers indicating Morfan syndrome. Because of its extreme rarity, there is no specific diagnostic algorithm for Morfan syndrome. As additional cases are reported, we hope that further biochemical, physical, and genetic studies may be pursued to better identify the syndrome and elucidate its pathogenesis.
1. Seemanová E, Rüdiger HW, Dreyer M. Morfan: a new syndrome characterized by mental retardation, pre- and postnatal overgrowth, remarkable face and acanthosis nigricans in 5-year-old boy. Am J Med Genet. 1993;45:525-528.
2. Rendon MI, Cruz PD Jr, Sontheimer RD, et al. Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin. J Am Acad Dermatol. 1989;21:461-469.
3. Unna PG, Morris M, Besnier E, eds. International Atlas of Rare Skin Diseases. London, England: HK Lewis & Co; 1890.
4. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994;31:1-19.
5. Inamdar AC, Palit A. Generalized acanthosis nigricans in childhood. Pediatr Dermatol. 2004;21:277-279.
6. Cruz PD, Hud JA. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J Invest Dermatol. 1992;98:82-85.
7. Krawczyk M, Mykała-Cies´la J, Kołodziej-Jaskuła A. Acanthosis nigricans as a paraneoplastic syndrome. case reports and review of literature. Pol Arch Med Wewn. 2009;119:180-183.
8. Meyers GA, Orlow SJ, Munro IR, et al. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nature Genet. 1995;11:462-464.
9. Moller DE, Cohen O, Yamaguchi Y, et al. Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes. 1994;43:247-255.
10. Przylepa KA, Paznekas W, Zhang M, et al. Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nature Genet. 1996;13:492-494.
11. Anderson JL, Khan M, David WS, et al. Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22. Am J Med Genet. 1992;82:161-165.
12. Simha V, Agarwal AK, Aronin PA, et al. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability. Am J Med Genet. 2008;146A:2318-2326.
13. Kahn CR, Flier JS, Bar RS, et al. the syndromes of insulin resistance and acanthosis nigricans. insulin-receptor disorders in man. N Engl J Med. 1976;294:739-745.
14. Brickman WWJ, Huang J, Silverman BL, et al. Acanthosis nigricans identifies youth at high risk for metabolic abnormalities. J Pediatr. 2010;156:87-92.
15. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. insulin-like growth factors.
N Engl J Med. 1997;336:633-640.
16. Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev. 2001;22:818-835.
17. Berk DR, Spector EB, Bayliss SJ. Familial acanthosis nigricans due to K650T FGFR3 mutation. Arch Dermatol. 2007;143:1153-1156.
1. Seemanová E, Rüdiger HW, Dreyer M. Morfan: a new syndrome characterized by mental retardation, pre- and postnatal overgrowth, remarkable face and acanthosis nigricans in 5-year-old boy. Am J Med Genet. 1993;45:525-528.
2. Rendon MI, Cruz PD Jr, Sontheimer RD, et al. Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin. J Am Acad Dermatol. 1989;21:461-469.
3. Unna PG, Morris M, Besnier E, eds. International Atlas of Rare Skin Diseases. London, England: HK Lewis & Co; 1890.
4. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994;31:1-19.
5. Inamdar AC, Palit A. Generalized acanthosis nigricans in childhood. Pediatr Dermatol. 2004;21:277-279.
6. Cruz PD, Hud JA. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J Invest Dermatol. 1992;98:82-85.
7. Krawczyk M, Mykała-Cies´la J, Kołodziej-Jaskuła A. Acanthosis nigricans as a paraneoplastic syndrome. case reports and review of literature. Pol Arch Med Wewn. 2009;119:180-183.
8. Meyers GA, Orlow SJ, Munro IR, et al. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nature Genet. 1995;11:462-464.
9. Moller DE, Cohen O, Yamaguchi Y, et al. Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes. 1994;43:247-255.
10. Przylepa KA, Paznekas W, Zhang M, et al. Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nature Genet. 1996;13:492-494.
11. Anderson JL, Khan M, David WS, et al. Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22. Am J Med Genet. 1992;82:161-165.
12. Simha V, Agarwal AK, Aronin PA, et al. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability. Am J Med Genet. 2008;146A:2318-2326.
13. Kahn CR, Flier JS, Bar RS, et al. the syndromes of insulin resistance and acanthosis nigricans. insulin-receptor disorders in man. N Engl J Med. 1976;294:739-745.
14. Brickman WWJ, Huang J, Silverman BL, et al. Acanthosis nigricans identifies youth at high risk for metabolic abnormalities. J Pediatr. 2010;156:87-92.
15. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. insulin-like growth factors.
N Engl J Med. 1997;336:633-640.
16. Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev. 2001;22:818-835.
17. Berk DR, Spector EB, Bayliss SJ. Familial acanthosis nigricans due to K650T FGFR3 mutation. Arch Dermatol. 2007;143:1153-1156.
Plasmapheresis in Refractory Pemphigus Vulgaris: Revisiting an Old Treatment Modality Used in Synchrony With Pulse Cyclophosphamide
To the Editor:
Pemphigus vulgaris is an uncommon autoimmune blistering dermatosis characterized by painful mucocutaneous erosions. It can be a life-threatening condition if left untreated. The autoimmune process is mediated by autoantibodies against the keratinocyte surface antigens desmoglein 1 and 3.1 Therapy is directed at lowering autoantibody levels with systemic corticosteroids and immunosuppressive agents. Use of these agents often is limited by collateral adverse effects.2 Refractory disease may occur despite the use of high-dose corticosteroids or a combination of other immunosuppressants. The level of these pathogenic autoantibodies generally parallels the extent of disease activity, and removing them with plasmapheresis followed by immunosuppression should result in therapeutic response.3 We report a case of refractory pemphigus vulgaris that was controlled with plasmapheresis used in synchrony with pulse cyclophosphamide.
A 48-year-old Chinese man first presented with mucocutaneous erosions 2 years ago, and a diagnosis of pemphigus vulgaris was confirmed based on typical histologic and immunofluorescence features. Histologic features included suprabasal acantholysis with an intraepidermal blister as well as basal keratinocytes attached to the dermal papillae and present along the entire dermoepidermal junction (Figure 1). Direct immunofluorescence demonstrated intercellular deposits of IgG and complements in the lower epidermis, and indirect immunofluorescence showed the presence of the pathogenic pemphigus autoantibodies. The patient was initially treated with prednisolone (up to 1 mg/kg daily) and mycophenolate mofetil (1 g twice daily) for 6 months with moderate disease response. Two months later he experienced a disease flare that was triggered by sun exposure and concomitant herpes simplex virus infection. He achieved moderate disease control with acyclovir, 3 days of intravenous immunoglobulin, and combination prednisolone and azathioprine. There was no other relevant medical history. For the last year, the patient received continuous prednisolone (varying doses 0.5–1 mg/kg daily), concomitant azathioprine (up to 3 mg/kg daily), and long-term prophylactic acyclovir, but he continued to have residual crusted erosions over the scalp and face (best score of 25 points based on the autoimmune bullous skin disorder intensity score [ABSIS] ranging from 0–150 points4). He was admitted at the current presentation with another, more severe disease flare with extensive painful erosions over the trunk, arms, legs, face, and scalp (80% body surface area involvement and ABSIS score of 120 points)(Figure 2)4 that occurred after azathioprine was temporarily ceased for 1 week due to transaminitis, and despite a temporary increment in prednisolone dose. There was, however, no significant oral mucosal involvement. The desmoglein 1 and 3 antibody levels were elevated at more than 300 U/mL and 186 U/mL, respectively (>20 U/mL indicates positivity). A 3-day course of pulse intravenous methylprednisolone (10 mg/kg) failed to achieve clinical improvement or reduction of antibody titers. The use of various immunosuppressive agents was limited by persistent transaminitis and transient leukopenia.
|
Because of remarkable morbidity, the patient underwent interim plasmapheresis for rapid disease control. Plasmapheresis was carried out through a pheresible central venous catheter. One plasma volume exchange was done each session, which was 5 L for the patient’s body weight and hematocrit. Equal volume of colloid comprising 2.5 L of fresh frozen plasma and 2.5 L of 5% albumin was used for replacement. Plasma exchange was performed with a cell separator by discontinuous flow centrifugation with 4% acid citrate dextrose as an anticoagulant. For each session of plasmapheresis, 16 cycles of exchange (each processing approximately 300 mL of blood) was carried out, the entire process lasting for 4 hours. The coagulation and biochemical profile was checked after each session of plasmapheresis and corrected when necessary. The patient underwent 9 sessions of plasmapheresis over a 3-week period, synchronized with pulse intravenous cyclophosphamide (15 mg/kg) immediately after completion of the plasmapheresis sessions, resulting in a remarkable decrease in pathogenic antibody titers to near undetectable levels and clinical improvement (Figure 3). The extensive erosions gradually healed with good reepithelialization, and there was a notable reduction in the ABSIS score to 12 points. He received 3 more monthly treatments with pulse intravenous cyclophosphamide (15 mg/kg) and is currently maintained on oral cyclophosphamide (2 mg/kg daily) and low-dose prednisolone (0.3 mg/kg daily). There was no subsequent disease relapse at 6-month follow-up, with the ABSIS score maintained at 5 points, and no increase in pathogenic autoantibody titers. The patient subsequently was lost to follow-up.
Patients with severe disease or refractory cases of pemphigus vulgaris that have been maintained on unacceptably high doses of corticosteroids or immunosuppressants that cannot be tapered without a disease flare may develop remarkable adverse effects, both from medications and from long-term immunosuppression.2 Our case illustrates the short-term benefit of plasmapheresis combined with immunosuppressants resulting in rapid disease control.
Plasmapheresis involves the selective removal of pathogenic materials from the circulation to achieve therapeutic effect, followed by appropriate replacement fluids. Treating pemphigus vulgaris with plasmapheresis was introduced in 1978 based on the rationale of removing pathogenic autoantibodies from the circulation.3,5 Using desmoglein enzyme-linked immunosorbent assay, it has been shown that one centrifugal plasmapheresis procedure eliminates approximately 15% of the IgG autoantibodies from the whole body.6 An average of 5 plasmapheresis sessions on alternate days usually is required to deplete the levels of pathogenic autoantibodies to near undetectable levels.7 Our case required 9 plasmapheresis sessions over 3 weeks to achieve good therapeutic response.
It seems that using plasmapheresis to treat pemphigus vulgaris has fallen out of favor due to its inability to prevent the antibody rebound occurring during weeks 1 and 2 posttreatment. Because of a feedback mechanism, a massive antibody depletion by plasmapheresis triggers a rebound synthesis of more autoantibodies by pathogenic B cells to titers comparable to or higher than those before plasmapheresis.8 The use of plasmapheresis should be supported by immunosuppressive therapy to prevent antibody feedback rebound. Due to the advent of available immunosuppressive agents in recent years, there is a resurgence in the successful use of this old treatment modality combined with immunosuppressive therapy in managing refractory pemphigus vulgaris.7,8 At present there is no clear data to support the use of one immunosuppressant versus another, but our case supports the use of pulse intravenous cyclophosphamide, as documented in other reports.7,9 The success of immunosuppressive agents at reducing antibody levels depends on the timing (immediately after plasmapheresis) as well as individual responsiveness to the immunosuppressant.7
Our armamentarium of therapies for refractory pemphigus vulgaris continues to evolve. A more selective method of removing antibodies by extracorporeal immunoadsorption has the benefit of higher removal rates and reduced inadvertent loss of other plasma components.10 The combination of protein A immunoadsorption with rituximab, a monoclonal anti-CD20 antibody that induces B-cell depletion, also has been shown to induce rapid and durable remission in refractory cases.11
Our case shows that plasmapheresis can be a useful alternative or adjunctive intervention in pemphigus vulgaris that is not responding to conventional therapy or in cases when steroids or immunosuppressants are contraindicated. There is a definite role for such therapeutic plasma exchanges in the rapid control of potentially life-threatening disease. Its benefits are optimized when used in synchrony with immunosuppressants immediately following plasmapheresis to prevent rebound effect of antibody depletion.
1. Udey MC, Stanley JR. Pemphigus–disease of antidesmosomal autoimmunity. JAMA. 1999;282:572-576.
2. Huilgol SC, Black MM. Management of the immunobullous disorders. II. pemphigus. Clin Exp Dermatol. 1995;20:283-293.
3. Cotterill JA, Barker DJ, Millard LG. Plasma exchange in the treatment of pemphigus vulgaris. Br J Dermatol. 1978;98:243.
4. Pfutze M, Niedermeier A, Hertl M, et al. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus [published online ahead of print February 27, 2007]. Eur J Dermatol. 2007;17:4-11.
5. Ruocco V, Rossi A, Argenziano G, et al. Pathogenicity of the intercellular antibodies of pemphigus their periodic removal from the circulation by plasmapheresis. Br J Dermatol. 1978;98:237-241.
6. Nagasaka T, Fujii Y, Ishida A, et al. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay [published online ahead of print January 30, 2008]. Br J Dermatol. 2008;158:685-690.
7. Turner MS, Sutton D, Sauder DN. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris. J Am Acad Dermatol. 2000;43:1058-1064.
8. Roujeau JC, Andre C, Joneau Fabre M, et al. Plasma exchange in pemphigus. uncontrolled study of ten patients. Arch Dermatol. 1983;119:215-221.
9. Euler HH, Löffler H, Christophers E. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris. Arch Dermatol. 1987;123:1205-1210.
10. Lüftl M, Stauber A, Mainka A, et al. Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber. Br J Dermatol. 2003;149:598-605.
11. Shimanovich I, Nitschke M, Rose C, et al. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins. Br J Dermatol. 2008;158:382-388.
To the Editor:
Pemphigus vulgaris is an uncommon autoimmune blistering dermatosis characterized by painful mucocutaneous erosions. It can be a life-threatening condition if left untreated. The autoimmune process is mediated by autoantibodies against the keratinocyte surface antigens desmoglein 1 and 3.1 Therapy is directed at lowering autoantibody levels with systemic corticosteroids and immunosuppressive agents. Use of these agents often is limited by collateral adverse effects.2 Refractory disease may occur despite the use of high-dose corticosteroids or a combination of other immunosuppressants. The level of these pathogenic autoantibodies generally parallels the extent of disease activity, and removing them with plasmapheresis followed by immunosuppression should result in therapeutic response.3 We report a case of refractory pemphigus vulgaris that was controlled with plasmapheresis used in synchrony with pulse cyclophosphamide.
A 48-year-old Chinese man first presented with mucocutaneous erosions 2 years ago, and a diagnosis of pemphigus vulgaris was confirmed based on typical histologic and immunofluorescence features. Histologic features included suprabasal acantholysis with an intraepidermal blister as well as basal keratinocytes attached to the dermal papillae and present along the entire dermoepidermal junction (Figure 1). Direct immunofluorescence demonstrated intercellular deposits of IgG and complements in the lower epidermis, and indirect immunofluorescence showed the presence of the pathogenic pemphigus autoantibodies. The patient was initially treated with prednisolone (up to 1 mg/kg daily) and mycophenolate mofetil (1 g twice daily) for 6 months with moderate disease response. Two months later he experienced a disease flare that was triggered by sun exposure and concomitant herpes simplex virus infection. He achieved moderate disease control with acyclovir, 3 days of intravenous immunoglobulin, and combination prednisolone and azathioprine. There was no other relevant medical history. For the last year, the patient received continuous prednisolone (varying doses 0.5–1 mg/kg daily), concomitant azathioprine (up to 3 mg/kg daily), and long-term prophylactic acyclovir, but he continued to have residual crusted erosions over the scalp and face (best score of 25 points based on the autoimmune bullous skin disorder intensity score [ABSIS] ranging from 0–150 points4). He was admitted at the current presentation with another, more severe disease flare with extensive painful erosions over the trunk, arms, legs, face, and scalp (80% body surface area involvement and ABSIS score of 120 points)(Figure 2)4 that occurred after azathioprine was temporarily ceased for 1 week due to transaminitis, and despite a temporary increment in prednisolone dose. There was, however, no significant oral mucosal involvement. The desmoglein 1 and 3 antibody levels were elevated at more than 300 U/mL and 186 U/mL, respectively (>20 U/mL indicates positivity). A 3-day course of pulse intravenous methylprednisolone (10 mg/kg) failed to achieve clinical improvement or reduction of antibody titers. The use of various immunosuppressive agents was limited by persistent transaminitis and transient leukopenia.
|
Because of remarkable morbidity, the patient underwent interim plasmapheresis for rapid disease control. Plasmapheresis was carried out through a pheresible central venous catheter. One plasma volume exchange was done each session, which was 5 L for the patient’s body weight and hematocrit. Equal volume of colloid comprising 2.5 L of fresh frozen plasma and 2.5 L of 5% albumin was used for replacement. Plasma exchange was performed with a cell separator by discontinuous flow centrifugation with 4% acid citrate dextrose as an anticoagulant. For each session of plasmapheresis, 16 cycles of exchange (each processing approximately 300 mL of blood) was carried out, the entire process lasting for 4 hours. The coagulation and biochemical profile was checked after each session of plasmapheresis and corrected when necessary. The patient underwent 9 sessions of plasmapheresis over a 3-week period, synchronized with pulse intravenous cyclophosphamide (15 mg/kg) immediately after completion of the plasmapheresis sessions, resulting in a remarkable decrease in pathogenic antibody titers to near undetectable levels and clinical improvement (Figure 3). The extensive erosions gradually healed with good reepithelialization, and there was a notable reduction in the ABSIS score to 12 points. He received 3 more monthly treatments with pulse intravenous cyclophosphamide (15 mg/kg) and is currently maintained on oral cyclophosphamide (2 mg/kg daily) and low-dose prednisolone (0.3 mg/kg daily). There was no subsequent disease relapse at 6-month follow-up, with the ABSIS score maintained at 5 points, and no increase in pathogenic autoantibody titers. The patient subsequently was lost to follow-up.
Patients with severe disease or refractory cases of pemphigus vulgaris that have been maintained on unacceptably high doses of corticosteroids or immunosuppressants that cannot be tapered without a disease flare may develop remarkable adverse effects, both from medications and from long-term immunosuppression.2 Our case illustrates the short-term benefit of plasmapheresis combined with immunosuppressants resulting in rapid disease control.
Plasmapheresis involves the selective removal of pathogenic materials from the circulation to achieve therapeutic effect, followed by appropriate replacement fluids. Treating pemphigus vulgaris with plasmapheresis was introduced in 1978 based on the rationale of removing pathogenic autoantibodies from the circulation.3,5 Using desmoglein enzyme-linked immunosorbent assay, it has been shown that one centrifugal plasmapheresis procedure eliminates approximately 15% of the IgG autoantibodies from the whole body.6 An average of 5 plasmapheresis sessions on alternate days usually is required to deplete the levels of pathogenic autoantibodies to near undetectable levels.7 Our case required 9 plasmapheresis sessions over 3 weeks to achieve good therapeutic response.
It seems that using plasmapheresis to treat pemphigus vulgaris has fallen out of favor due to its inability to prevent the antibody rebound occurring during weeks 1 and 2 posttreatment. Because of a feedback mechanism, a massive antibody depletion by plasmapheresis triggers a rebound synthesis of more autoantibodies by pathogenic B cells to titers comparable to or higher than those before plasmapheresis.8 The use of plasmapheresis should be supported by immunosuppressive therapy to prevent antibody feedback rebound. Due to the advent of available immunosuppressive agents in recent years, there is a resurgence in the successful use of this old treatment modality combined with immunosuppressive therapy in managing refractory pemphigus vulgaris.7,8 At present there is no clear data to support the use of one immunosuppressant versus another, but our case supports the use of pulse intravenous cyclophosphamide, as documented in other reports.7,9 The success of immunosuppressive agents at reducing antibody levels depends on the timing (immediately after plasmapheresis) as well as individual responsiveness to the immunosuppressant.7
Our armamentarium of therapies for refractory pemphigus vulgaris continues to evolve. A more selective method of removing antibodies by extracorporeal immunoadsorption has the benefit of higher removal rates and reduced inadvertent loss of other plasma components.10 The combination of protein A immunoadsorption with rituximab, a monoclonal anti-CD20 antibody that induces B-cell depletion, also has been shown to induce rapid and durable remission in refractory cases.11
Our case shows that plasmapheresis can be a useful alternative or adjunctive intervention in pemphigus vulgaris that is not responding to conventional therapy or in cases when steroids or immunosuppressants are contraindicated. There is a definite role for such therapeutic plasma exchanges in the rapid control of potentially life-threatening disease. Its benefits are optimized when used in synchrony with immunosuppressants immediately following plasmapheresis to prevent rebound effect of antibody depletion.
To the Editor:
Pemphigus vulgaris is an uncommon autoimmune blistering dermatosis characterized by painful mucocutaneous erosions. It can be a life-threatening condition if left untreated. The autoimmune process is mediated by autoantibodies against the keratinocyte surface antigens desmoglein 1 and 3.1 Therapy is directed at lowering autoantibody levels with systemic corticosteroids and immunosuppressive agents. Use of these agents often is limited by collateral adverse effects.2 Refractory disease may occur despite the use of high-dose corticosteroids or a combination of other immunosuppressants. The level of these pathogenic autoantibodies generally parallels the extent of disease activity, and removing them with plasmapheresis followed by immunosuppression should result in therapeutic response.3 We report a case of refractory pemphigus vulgaris that was controlled with plasmapheresis used in synchrony with pulse cyclophosphamide.
A 48-year-old Chinese man first presented with mucocutaneous erosions 2 years ago, and a diagnosis of pemphigus vulgaris was confirmed based on typical histologic and immunofluorescence features. Histologic features included suprabasal acantholysis with an intraepidermal blister as well as basal keratinocytes attached to the dermal papillae and present along the entire dermoepidermal junction (Figure 1). Direct immunofluorescence demonstrated intercellular deposits of IgG and complements in the lower epidermis, and indirect immunofluorescence showed the presence of the pathogenic pemphigus autoantibodies. The patient was initially treated with prednisolone (up to 1 mg/kg daily) and mycophenolate mofetil (1 g twice daily) for 6 months with moderate disease response. Two months later he experienced a disease flare that was triggered by sun exposure and concomitant herpes simplex virus infection. He achieved moderate disease control with acyclovir, 3 days of intravenous immunoglobulin, and combination prednisolone and azathioprine. There was no other relevant medical history. For the last year, the patient received continuous prednisolone (varying doses 0.5–1 mg/kg daily), concomitant azathioprine (up to 3 mg/kg daily), and long-term prophylactic acyclovir, but he continued to have residual crusted erosions over the scalp and face (best score of 25 points based on the autoimmune bullous skin disorder intensity score [ABSIS] ranging from 0–150 points4). He was admitted at the current presentation with another, more severe disease flare with extensive painful erosions over the trunk, arms, legs, face, and scalp (80% body surface area involvement and ABSIS score of 120 points)(Figure 2)4 that occurred after azathioprine was temporarily ceased for 1 week due to transaminitis, and despite a temporary increment in prednisolone dose. There was, however, no significant oral mucosal involvement. The desmoglein 1 and 3 antibody levels were elevated at more than 300 U/mL and 186 U/mL, respectively (>20 U/mL indicates positivity). A 3-day course of pulse intravenous methylprednisolone (10 mg/kg) failed to achieve clinical improvement or reduction of antibody titers. The use of various immunosuppressive agents was limited by persistent transaminitis and transient leukopenia.
|
Because of remarkable morbidity, the patient underwent interim plasmapheresis for rapid disease control. Plasmapheresis was carried out through a pheresible central venous catheter. One plasma volume exchange was done each session, which was 5 L for the patient’s body weight and hematocrit. Equal volume of colloid comprising 2.5 L of fresh frozen plasma and 2.5 L of 5% albumin was used for replacement. Plasma exchange was performed with a cell separator by discontinuous flow centrifugation with 4% acid citrate dextrose as an anticoagulant. For each session of plasmapheresis, 16 cycles of exchange (each processing approximately 300 mL of blood) was carried out, the entire process lasting for 4 hours. The coagulation and biochemical profile was checked after each session of plasmapheresis and corrected when necessary. The patient underwent 9 sessions of plasmapheresis over a 3-week period, synchronized with pulse intravenous cyclophosphamide (15 mg/kg) immediately after completion of the plasmapheresis sessions, resulting in a remarkable decrease in pathogenic antibody titers to near undetectable levels and clinical improvement (Figure 3). The extensive erosions gradually healed with good reepithelialization, and there was a notable reduction in the ABSIS score to 12 points. He received 3 more monthly treatments with pulse intravenous cyclophosphamide (15 mg/kg) and is currently maintained on oral cyclophosphamide (2 mg/kg daily) and low-dose prednisolone (0.3 mg/kg daily). There was no subsequent disease relapse at 6-month follow-up, with the ABSIS score maintained at 5 points, and no increase in pathogenic autoantibody titers. The patient subsequently was lost to follow-up.
Patients with severe disease or refractory cases of pemphigus vulgaris that have been maintained on unacceptably high doses of corticosteroids or immunosuppressants that cannot be tapered without a disease flare may develop remarkable adverse effects, both from medications and from long-term immunosuppression.2 Our case illustrates the short-term benefit of plasmapheresis combined with immunosuppressants resulting in rapid disease control.
Plasmapheresis involves the selective removal of pathogenic materials from the circulation to achieve therapeutic effect, followed by appropriate replacement fluids. Treating pemphigus vulgaris with plasmapheresis was introduced in 1978 based on the rationale of removing pathogenic autoantibodies from the circulation.3,5 Using desmoglein enzyme-linked immunosorbent assay, it has been shown that one centrifugal plasmapheresis procedure eliminates approximately 15% of the IgG autoantibodies from the whole body.6 An average of 5 plasmapheresis sessions on alternate days usually is required to deplete the levels of pathogenic autoantibodies to near undetectable levels.7 Our case required 9 plasmapheresis sessions over 3 weeks to achieve good therapeutic response.
It seems that using plasmapheresis to treat pemphigus vulgaris has fallen out of favor due to its inability to prevent the antibody rebound occurring during weeks 1 and 2 posttreatment. Because of a feedback mechanism, a massive antibody depletion by plasmapheresis triggers a rebound synthesis of more autoantibodies by pathogenic B cells to titers comparable to or higher than those before plasmapheresis.8 The use of plasmapheresis should be supported by immunosuppressive therapy to prevent antibody feedback rebound. Due to the advent of available immunosuppressive agents in recent years, there is a resurgence in the successful use of this old treatment modality combined with immunosuppressive therapy in managing refractory pemphigus vulgaris.7,8 At present there is no clear data to support the use of one immunosuppressant versus another, but our case supports the use of pulse intravenous cyclophosphamide, as documented in other reports.7,9 The success of immunosuppressive agents at reducing antibody levels depends on the timing (immediately after plasmapheresis) as well as individual responsiveness to the immunosuppressant.7
Our armamentarium of therapies for refractory pemphigus vulgaris continues to evolve. A more selective method of removing antibodies by extracorporeal immunoadsorption has the benefit of higher removal rates and reduced inadvertent loss of other plasma components.10 The combination of protein A immunoadsorption with rituximab, a monoclonal anti-CD20 antibody that induces B-cell depletion, also has been shown to induce rapid and durable remission in refractory cases.11
Our case shows that plasmapheresis can be a useful alternative or adjunctive intervention in pemphigus vulgaris that is not responding to conventional therapy or in cases when steroids or immunosuppressants are contraindicated. There is a definite role for such therapeutic plasma exchanges in the rapid control of potentially life-threatening disease. Its benefits are optimized when used in synchrony with immunosuppressants immediately following plasmapheresis to prevent rebound effect of antibody depletion.
1. Udey MC, Stanley JR. Pemphigus–disease of antidesmosomal autoimmunity. JAMA. 1999;282:572-576.
2. Huilgol SC, Black MM. Management of the immunobullous disorders. II. pemphigus. Clin Exp Dermatol. 1995;20:283-293.
3. Cotterill JA, Barker DJ, Millard LG. Plasma exchange in the treatment of pemphigus vulgaris. Br J Dermatol. 1978;98:243.
4. Pfutze M, Niedermeier A, Hertl M, et al. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus [published online ahead of print February 27, 2007]. Eur J Dermatol. 2007;17:4-11.
5. Ruocco V, Rossi A, Argenziano G, et al. Pathogenicity of the intercellular antibodies of pemphigus their periodic removal from the circulation by plasmapheresis. Br J Dermatol. 1978;98:237-241.
6. Nagasaka T, Fujii Y, Ishida A, et al. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay [published online ahead of print January 30, 2008]. Br J Dermatol. 2008;158:685-690.
7. Turner MS, Sutton D, Sauder DN. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris. J Am Acad Dermatol. 2000;43:1058-1064.
8. Roujeau JC, Andre C, Joneau Fabre M, et al. Plasma exchange in pemphigus. uncontrolled study of ten patients. Arch Dermatol. 1983;119:215-221.
9. Euler HH, Löffler H, Christophers E. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris. Arch Dermatol. 1987;123:1205-1210.
10. Lüftl M, Stauber A, Mainka A, et al. Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber. Br J Dermatol. 2003;149:598-605.
11. Shimanovich I, Nitschke M, Rose C, et al. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins. Br J Dermatol. 2008;158:382-388.
1. Udey MC, Stanley JR. Pemphigus–disease of antidesmosomal autoimmunity. JAMA. 1999;282:572-576.
2. Huilgol SC, Black MM. Management of the immunobullous disorders. II. pemphigus. Clin Exp Dermatol. 1995;20:283-293.
3. Cotterill JA, Barker DJ, Millard LG. Plasma exchange in the treatment of pemphigus vulgaris. Br J Dermatol. 1978;98:243.
4. Pfutze M, Niedermeier A, Hertl M, et al. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus [published online ahead of print February 27, 2007]. Eur J Dermatol. 2007;17:4-11.
5. Ruocco V, Rossi A, Argenziano G, et al. Pathogenicity of the intercellular antibodies of pemphigus their periodic removal from the circulation by plasmapheresis. Br J Dermatol. 1978;98:237-241.
6. Nagasaka T, Fujii Y, Ishida A, et al. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay [published online ahead of print January 30, 2008]. Br J Dermatol. 2008;158:685-690.
7. Turner MS, Sutton D, Sauder DN. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris. J Am Acad Dermatol. 2000;43:1058-1064.
8. Roujeau JC, Andre C, Joneau Fabre M, et al. Plasma exchange in pemphigus. uncontrolled study of ten patients. Arch Dermatol. 1983;119:215-221.
9. Euler HH, Löffler H, Christophers E. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris. Arch Dermatol. 1987;123:1205-1210.
10. Lüftl M, Stauber A, Mainka A, et al. Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber. Br J Dermatol. 2003;149:598-605.
11. Shimanovich I, Nitschke M, Rose C, et al. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins. Br J Dermatol. 2008;158:382-388.
Identification of Cutaneous Warts: Cryotherapy-Induced Acetowhitelike Epithelium
To the Editor:
Cutaneous warts are benign proliferations of the epidermis that occur secondary to human papillomavirus (HPV) infection. The diagnosis of cutaneous warts is generally based on clinical appearance. Occasionally subtle lesions, particularly those of verruca plana, escape clinical identification leading to incomplete treatment and spreading. The acetic acid test (sometimes called the acetic acid visual inspection) causes epithelial whitening of HPV-infected areas after application of a 3% to 5% aqueous solution of acetic acid and has been used to detect subclinical HPV infection.1 Although the acetic acid test can support the diagnosis of cutaneous warts, it is more effective at detecting hyperplastic rather than flat warts and may be cumbersome to use routinely.2 We describe a simple clinical maneuver to help confirm the presence of subtle warts using gentle liquid nitrogen cryotherapy to induce epithelial whitening in areas of HPV infection.
A 22-year-old man presented for evaluation of a 5-mm verrucous papule on the right wrist. He was diagnosed with verruca vulgaris. During treatment, small satellite verrucous papules were visualized by differential whitening from the surrounding uninfected skin (Figure). A brief light spray of liquid nitrogen cryotherapy (-196°C) was applied over areas containing suspicious lesions for confirmation. This acetowhitelike change from indirect collateral cryotherapy allowed for identification and treatment of these subtle warts.
Cutaneous warts represent foci of epithelial proliferation, and acetowhite changes are thought to occur from extravasation of intracellular water with subsequent tissue whitening in areas of high nuclear density.3 Acetowhite epithelium also has been reported after other ablative wart therapies.4 Similarly, acetowhitelike changes after cryotherapy may be secondary to cellular dehydration from ice crystal formation,5 with HPV-infected areas demonstrating increased susceptibility to freezing because of increased cellular water content in areas of hyperkeratosis. In addition, it has been demonstrated that cryotherapy alters the composition of the epithelium by destroying neutral and acidic mucopolysaccharides, which may subsequently induce the characteristic acetowhitelike changes in the epithelium of cutaneous warts.6
We propose that gentle painless sprays of liquid nitrogen to areas with suspicious lesions can help confirm the presence of subtle warts through cryotherapy-induced epithelial whitening. Although this test is a valuable diagnostic pearl, it should be noted that cryotherapy may accentuate an area of hyperkeratosis from causes other than an HPV infection. As such, clinical judgment is required.
1. Allan BM. Acetowhite epithelium. Gynecol Oncol. 2004;95:691-694.
2. Kumar B, Gupta S. The acetowhite test in genital human papillomavirus infection in men: what does it add? J Eur Acad Dermatol Venereol. 2001;15:27-29.
3. O’Connor DM. A tissue basis for colposcopic findings. Obstet Gynecol Clin North Am. 2008;35:565-582.
4. MacLean AB. Healing of the cervical epithelium after laser treatment of cervical intraepithelial neoplasia. Br J Obstet Gynaecol. 1984;91:697-706.
5. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37:171-186.
6. Ciecierski L. Histochemical studies on acid and neutral mucopolysaccharides in the acanthotic epidermis of warts before and after cryotherapy with liquid nitrogen. Przegl Dermatol. 1970;57:11-15.
To the Editor:
Cutaneous warts are benign proliferations of the epidermis that occur secondary to human papillomavirus (HPV) infection. The diagnosis of cutaneous warts is generally based on clinical appearance. Occasionally subtle lesions, particularly those of verruca plana, escape clinical identification leading to incomplete treatment and spreading. The acetic acid test (sometimes called the acetic acid visual inspection) causes epithelial whitening of HPV-infected areas after application of a 3% to 5% aqueous solution of acetic acid and has been used to detect subclinical HPV infection.1 Although the acetic acid test can support the diagnosis of cutaneous warts, it is more effective at detecting hyperplastic rather than flat warts and may be cumbersome to use routinely.2 We describe a simple clinical maneuver to help confirm the presence of subtle warts using gentle liquid nitrogen cryotherapy to induce epithelial whitening in areas of HPV infection.
A 22-year-old man presented for evaluation of a 5-mm verrucous papule on the right wrist. He was diagnosed with verruca vulgaris. During treatment, small satellite verrucous papules were visualized by differential whitening from the surrounding uninfected skin (Figure). A brief light spray of liquid nitrogen cryotherapy (-196°C) was applied over areas containing suspicious lesions for confirmation. This acetowhitelike change from indirect collateral cryotherapy allowed for identification and treatment of these subtle warts.
Cutaneous warts represent foci of epithelial proliferation, and acetowhite changes are thought to occur from extravasation of intracellular water with subsequent tissue whitening in areas of high nuclear density.3 Acetowhite epithelium also has been reported after other ablative wart therapies.4 Similarly, acetowhitelike changes after cryotherapy may be secondary to cellular dehydration from ice crystal formation,5 with HPV-infected areas demonstrating increased susceptibility to freezing because of increased cellular water content in areas of hyperkeratosis. In addition, it has been demonstrated that cryotherapy alters the composition of the epithelium by destroying neutral and acidic mucopolysaccharides, which may subsequently induce the characteristic acetowhitelike changes in the epithelium of cutaneous warts.6
We propose that gentle painless sprays of liquid nitrogen to areas with suspicious lesions can help confirm the presence of subtle warts through cryotherapy-induced epithelial whitening. Although this test is a valuable diagnostic pearl, it should be noted that cryotherapy may accentuate an area of hyperkeratosis from causes other than an HPV infection. As such, clinical judgment is required.
To the Editor:
Cutaneous warts are benign proliferations of the epidermis that occur secondary to human papillomavirus (HPV) infection. The diagnosis of cutaneous warts is generally based on clinical appearance. Occasionally subtle lesions, particularly those of verruca plana, escape clinical identification leading to incomplete treatment and spreading. The acetic acid test (sometimes called the acetic acid visual inspection) causes epithelial whitening of HPV-infected areas after application of a 3% to 5% aqueous solution of acetic acid and has been used to detect subclinical HPV infection.1 Although the acetic acid test can support the diagnosis of cutaneous warts, it is more effective at detecting hyperplastic rather than flat warts and may be cumbersome to use routinely.2 We describe a simple clinical maneuver to help confirm the presence of subtle warts using gentle liquid nitrogen cryotherapy to induce epithelial whitening in areas of HPV infection.
A 22-year-old man presented for evaluation of a 5-mm verrucous papule on the right wrist. He was diagnosed with verruca vulgaris. During treatment, small satellite verrucous papules were visualized by differential whitening from the surrounding uninfected skin (Figure). A brief light spray of liquid nitrogen cryotherapy (-196°C) was applied over areas containing suspicious lesions for confirmation. This acetowhitelike change from indirect collateral cryotherapy allowed for identification and treatment of these subtle warts.
Cutaneous warts represent foci of epithelial proliferation, and acetowhite changes are thought to occur from extravasation of intracellular water with subsequent tissue whitening in areas of high nuclear density.3 Acetowhite epithelium also has been reported after other ablative wart therapies.4 Similarly, acetowhitelike changes after cryotherapy may be secondary to cellular dehydration from ice crystal formation,5 with HPV-infected areas demonstrating increased susceptibility to freezing because of increased cellular water content in areas of hyperkeratosis. In addition, it has been demonstrated that cryotherapy alters the composition of the epithelium by destroying neutral and acidic mucopolysaccharides, which may subsequently induce the characteristic acetowhitelike changes in the epithelium of cutaneous warts.6
We propose that gentle painless sprays of liquid nitrogen to areas with suspicious lesions can help confirm the presence of subtle warts through cryotherapy-induced epithelial whitening. Although this test is a valuable diagnostic pearl, it should be noted that cryotherapy may accentuate an area of hyperkeratosis from causes other than an HPV infection. As such, clinical judgment is required.
1. Allan BM. Acetowhite epithelium. Gynecol Oncol. 2004;95:691-694.
2. Kumar B, Gupta S. The acetowhite test in genital human papillomavirus infection in men: what does it add? J Eur Acad Dermatol Venereol. 2001;15:27-29.
3. O’Connor DM. A tissue basis for colposcopic findings. Obstet Gynecol Clin North Am. 2008;35:565-582.
4. MacLean AB. Healing of the cervical epithelium after laser treatment of cervical intraepithelial neoplasia. Br J Obstet Gynaecol. 1984;91:697-706.
5. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37:171-186.
6. Ciecierski L. Histochemical studies on acid and neutral mucopolysaccharides in the acanthotic epidermis of warts before and after cryotherapy with liquid nitrogen. Przegl Dermatol. 1970;57:11-15.
1. Allan BM. Acetowhite epithelium. Gynecol Oncol. 2004;95:691-694.
2. Kumar B, Gupta S. The acetowhite test in genital human papillomavirus infection in men: what does it add? J Eur Acad Dermatol Venereol. 2001;15:27-29.
3. O’Connor DM. A tissue basis for colposcopic findings. Obstet Gynecol Clin North Am. 2008;35:565-582.
4. MacLean AB. Healing of the cervical epithelium after laser treatment of cervical intraepithelial neoplasia. Br J Obstet Gynaecol. 1984;91:697-706.
5. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37:171-186.
6. Ciecierski L. Histochemical studies on acid and neutral mucopolysaccharides in the acanthotic epidermis of warts before and after cryotherapy with liquid nitrogen. Przegl Dermatol. 1970;57:11-15.
Subcutaneous Sarcoidosis on Ultrasonography
To the Editor:
A 54-year-old woman presented with painless, firm, flesh-colored nodules measuring 1.0 to 1.5 cm in diameter on the extensor surface of the left forearm (Figure 1) and on the distal phalanx of the left thumb of 3 months’ duration. No other signs and symptoms were present. A detailed clinical examination revealed a slightly elevated erythrocyte sedimentation rate (24 mm/h [reference range, 0–20 mm/h]) and a high antinuclear antibody titer (1:3200 [reference range, <1:100])(anti–Sjögren syndrome anti-gen A, anti–Sjögren syndrome antigen B, anti-Ro52). Complete blood cell count, basic metabolic panel, liver function tests, urinalysis, pulmonary function tests, chest radiograph, and chest computed tomography all were normal. Hepatitis B antigen and antibody tests; hepatitis C antibody tests; and tuberculin test all were negative. An ophthalmic examination revealed no abnormalities. Ultrasonography of the nodules was performed with a system using an 8- to 12-MHz linear transducer and revealed 4 heterogenous hypoechoic lesions measuring up to 1.5 cm in size. Color Doppler images showed moderate hypervascularity (Figure 2). The largest nodule was excised. Histologic examination revealed noncaseating granulomas; special stains for microorganisms were negative. The histopathologic findings confirmed a diagnosis of sarcoidosis (Figure 3). The patient refused any medication. The nodules were stable at 6-month follow-up, then spontaneously resolved.
|
Subcutaneous sarcoidosis (SS) is a rare cutaneous expression of systemic sarcoidosis. The entity was first described by French physicians Darier and Roussy in 1904 as granulomatous panniculitis. Although their original study referred to a case of tuberculosis, the term Darier-Roussy sarcoid was coined and had been applied to a true sarcoid as well as to a variety of other forms of granulomatous panniculitis including those of infectious origin. A more accurate term subcutaneous sarcoidosis was established in 1984 by Vainsencher and Winkelmann.1
The most characteristic clinical picture of this disorder consists of the presence of multiple painless, firm, mobile nodules located on the extremities, most frequently the arms. However, other sites such as the trunk, buttocks, groin, head, face, and neck also have been reported.2,3
Marcoval et al2 demonstrated SS in only 2.1% of 480 patients with systemic sarcoidosis (10 patients). In the majority of these patients, subcutaneous nodules were the initial presentation of the disease.2 Ahmed and Harshad3 reported evidence of systemic involvement in 84.9% (45/53) of patients with SS. Chest involvement was the most common finding (eg, hilar lymphadenopathy, mediastinal adenopathy, interstitial pulmonary infiltration).3 Parotitis, uveitis, neuritis, and hepatosplenomegaly also have been noted systemically.4 The vast majority of reviews have suggested that SS has a relatively good prognosis. Ahmed and Harshad3 reported a satisfactory response to steroid treatment in all patients who received corticosteroids as the primary treatment. Subcutaneous sarcoidosis usually does not herald severe systemic involvement or chronic systemic complications. Both subcutaneous granulomas and hilar adenopathy may spontaneously resolve.
Interestingly, various autoimmune disease associations were seen in 6 of 21 patients (29%) in the study by Ahmed and Harshad3 including Hashimoto thyroiditis, rheumatoid arthritis, ulcerative colitis, systemic lupus erythematosus, and sicca syndrome. Barnadas et al5 reported a case of SS associated with vitiligo, pernicious anemia, and Hashimoto thyroiditis. Although our patient was not diagnosed with any particular autoimmune disease, an antinuclear antibody test was positive at a titer of 1:3200.
Our case is interesting for 2 reasons. First, it is a rare case of isolated SS. Thorough systemic evaluation showed no evidence of extracutaneous involvement. The literature only provides a few instances of isolated SS.6,7 Second, the sonographic appearance of SS is rare.8,9 Chen et al9 reported that gray-scale sonography revealed heterogenous, hypoechoic, well-demarcated plaquelike lesions with an intensive vascular pattern indicating Doppler hypervascularization. We obtained similar findings.
It has been widely acknowledged that sonographic findings of subcutaneous nodules tend to be nonspecific and overlapping. Color Doppler examination may show internal vessels both in malignant soft-tissue masses (eg, lymphoma, synovial sarcoma, liposarcoma, malignant fibrohistocytoma, metastases) and in benign lesions (eg, schwannoma, hemangioma, fibromatosis). However, the application of Doppler ultrasonography may restrict the diagnostic field, as it excludes nonvascularized benign masses such as lipomas as well as ganglion or epidermoid cysts. The ultimate diagnosis can only be made based on histopathology.
1. Vainsencher D, Winkelmann RK. Subcutaneous sarcoidosis. Arch Dermatol. 1984;120:1028-1031.
2. Marcoval J, Maña J, Moreno A, et al. Subcutaneous sarcoidosis—clinicopathological study of 10 cases. Br J Dermatol. 2005;153:790-794.
3. Ahmed I, Harshad SR. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease [published online ahead of print December 2, 2005]? J Am Acad Dermatol. 2006;54:55-60.
4. Dalle Vedove C, Colato C, Girolomoni G. Subcutaneous sarcoidosis: report of two cases and review of the literature [published online ahead of print April 2, 2011]. Clin Rheumatol. 2011;30:1123-1128.
5. Barnadas MA, Rodríguez-Arias JM, Alomar A. Subcutaneous sarcoidosis associated with vitiligo, pernicious anaemia and autoimmune thyroiditis. Clin Exp Dermatol. 2000;25:55-56.
6. Higgins EM, Salisbury JR, Du Vivier AW. Subcutaneous sarcoidosis. Clin Exp Dermatol. 1993;18:65-66.
7. Heller M, Soldano AC. Sarcoidosis with subcutaneous lesions. Dermatol Online J. 2008;14:1.
8. Bosni´c D, Baresi´c M, Bagatin D, et al. Subcutaneous sarcoidosis of the face [published online ahead of print March 15, 2010]. Intern Med. 2010;49:589-592.
9. Chen HH, Chen YM, Lan HH, et al. Sonographic appearance of subcutaneous sarcoidosis. J Ultrasound Med. 2009;28:813-816.
To the Editor:
A 54-year-old woman presented with painless, firm, flesh-colored nodules measuring 1.0 to 1.5 cm in diameter on the extensor surface of the left forearm (Figure 1) and on the distal phalanx of the left thumb of 3 months’ duration. No other signs and symptoms were present. A detailed clinical examination revealed a slightly elevated erythrocyte sedimentation rate (24 mm/h [reference range, 0–20 mm/h]) and a high antinuclear antibody titer (1:3200 [reference range, <1:100])(anti–Sjögren syndrome anti-gen A, anti–Sjögren syndrome antigen B, anti-Ro52). Complete blood cell count, basic metabolic panel, liver function tests, urinalysis, pulmonary function tests, chest radiograph, and chest computed tomography all were normal. Hepatitis B antigen and antibody tests; hepatitis C antibody tests; and tuberculin test all were negative. An ophthalmic examination revealed no abnormalities. Ultrasonography of the nodules was performed with a system using an 8- to 12-MHz linear transducer and revealed 4 heterogenous hypoechoic lesions measuring up to 1.5 cm in size. Color Doppler images showed moderate hypervascularity (Figure 2). The largest nodule was excised. Histologic examination revealed noncaseating granulomas; special stains for microorganisms were negative. The histopathologic findings confirmed a diagnosis of sarcoidosis (Figure 3). The patient refused any medication. The nodules were stable at 6-month follow-up, then spontaneously resolved.
|
Subcutaneous sarcoidosis (SS) is a rare cutaneous expression of systemic sarcoidosis. The entity was first described by French physicians Darier and Roussy in 1904 as granulomatous panniculitis. Although their original study referred to a case of tuberculosis, the term Darier-Roussy sarcoid was coined and had been applied to a true sarcoid as well as to a variety of other forms of granulomatous panniculitis including those of infectious origin. A more accurate term subcutaneous sarcoidosis was established in 1984 by Vainsencher and Winkelmann.1
The most characteristic clinical picture of this disorder consists of the presence of multiple painless, firm, mobile nodules located on the extremities, most frequently the arms. However, other sites such as the trunk, buttocks, groin, head, face, and neck also have been reported.2,3
Marcoval et al2 demonstrated SS in only 2.1% of 480 patients with systemic sarcoidosis (10 patients). In the majority of these patients, subcutaneous nodules were the initial presentation of the disease.2 Ahmed and Harshad3 reported evidence of systemic involvement in 84.9% (45/53) of patients with SS. Chest involvement was the most common finding (eg, hilar lymphadenopathy, mediastinal adenopathy, interstitial pulmonary infiltration).3 Parotitis, uveitis, neuritis, and hepatosplenomegaly also have been noted systemically.4 The vast majority of reviews have suggested that SS has a relatively good prognosis. Ahmed and Harshad3 reported a satisfactory response to steroid treatment in all patients who received corticosteroids as the primary treatment. Subcutaneous sarcoidosis usually does not herald severe systemic involvement or chronic systemic complications. Both subcutaneous granulomas and hilar adenopathy may spontaneously resolve.
Interestingly, various autoimmune disease associations were seen in 6 of 21 patients (29%) in the study by Ahmed and Harshad3 including Hashimoto thyroiditis, rheumatoid arthritis, ulcerative colitis, systemic lupus erythematosus, and sicca syndrome. Barnadas et al5 reported a case of SS associated with vitiligo, pernicious anemia, and Hashimoto thyroiditis. Although our patient was not diagnosed with any particular autoimmune disease, an antinuclear antibody test was positive at a titer of 1:3200.
Our case is interesting for 2 reasons. First, it is a rare case of isolated SS. Thorough systemic evaluation showed no evidence of extracutaneous involvement. The literature only provides a few instances of isolated SS.6,7 Second, the sonographic appearance of SS is rare.8,9 Chen et al9 reported that gray-scale sonography revealed heterogenous, hypoechoic, well-demarcated plaquelike lesions with an intensive vascular pattern indicating Doppler hypervascularization. We obtained similar findings.
It has been widely acknowledged that sonographic findings of subcutaneous nodules tend to be nonspecific and overlapping. Color Doppler examination may show internal vessels both in malignant soft-tissue masses (eg, lymphoma, synovial sarcoma, liposarcoma, malignant fibrohistocytoma, metastases) and in benign lesions (eg, schwannoma, hemangioma, fibromatosis). However, the application of Doppler ultrasonography may restrict the diagnostic field, as it excludes nonvascularized benign masses such as lipomas as well as ganglion or epidermoid cysts. The ultimate diagnosis can only be made based on histopathology.
To the Editor:
A 54-year-old woman presented with painless, firm, flesh-colored nodules measuring 1.0 to 1.5 cm in diameter on the extensor surface of the left forearm (Figure 1) and on the distal phalanx of the left thumb of 3 months’ duration. No other signs and symptoms were present. A detailed clinical examination revealed a slightly elevated erythrocyte sedimentation rate (24 mm/h [reference range, 0–20 mm/h]) and a high antinuclear antibody titer (1:3200 [reference range, <1:100])(anti–Sjögren syndrome anti-gen A, anti–Sjögren syndrome antigen B, anti-Ro52). Complete blood cell count, basic metabolic panel, liver function tests, urinalysis, pulmonary function tests, chest radiograph, and chest computed tomography all were normal. Hepatitis B antigen and antibody tests; hepatitis C antibody tests; and tuberculin test all were negative. An ophthalmic examination revealed no abnormalities. Ultrasonography of the nodules was performed with a system using an 8- to 12-MHz linear transducer and revealed 4 heterogenous hypoechoic lesions measuring up to 1.5 cm in size. Color Doppler images showed moderate hypervascularity (Figure 2). The largest nodule was excised. Histologic examination revealed noncaseating granulomas; special stains for microorganisms were negative. The histopathologic findings confirmed a diagnosis of sarcoidosis (Figure 3). The patient refused any medication. The nodules were stable at 6-month follow-up, then spontaneously resolved.
|
Subcutaneous sarcoidosis (SS) is a rare cutaneous expression of systemic sarcoidosis. The entity was first described by French physicians Darier and Roussy in 1904 as granulomatous panniculitis. Although their original study referred to a case of tuberculosis, the term Darier-Roussy sarcoid was coined and had been applied to a true sarcoid as well as to a variety of other forms of granulomatous panniculitis including those of infectious origin. A more accurate term subcutaneous sarcoidosis was established in 1984 by Vainsencher and Winkelmann.1
The most characteristic clinical picture of this disorder consists of the presence of multiple painless, firm, mobile nodules located on the extremities, most frequently the arms. However, other sites such as the trunk, buttocks, groin, head, face, and neck also have been reported.2,3
Marcoval et al2 demonstrated SS in only 2.1% of 480 patients with systemic sarcoidosis (10 patients). In the majority of these patients, subcutaneous nodules were the initial presentation of the disease.2 Ahmed and Harshad3 reported evidence of systemic involvement in 84.9% (45/53) of patients with SS. Chest involvement was the most common finding (eg, hilar lymphadenopathy, mediastinal adenopathy, interstitial pulmonary infiltration).3 Parotitis, uveitis, neuritis, and hepatosplenomegaly also have been noted systemically.4 The vast majority of reviews have suggested that SS has a relatively good prognosis. Ahmed and Harshad3 reported a satisfactory response to steroid treatment in all patients who received corticosteroids as the primary treatment. Subcutaneous sarcoidosis usually does not herald severe systemic involvement or chronic systemic complications. Both subcutaneous granulomas and hilar adenopathy may spontaneously resolve.
Interestingly, various autoimmune disease associations were seen in 6 of 21 patients (29%) in the study by Ahmed and Harshad3 including Hashimoto thyroiditis, rheumatoid arthritis, ulcerative colitis, systemic lupus erythematosus, and sicca syndrome. Barnadas et al5 reported a case of SS associated with vitiligo, pernicious anemia, and Hashimoto thyroiditis. Although our patient was not diagnosed with any particular autoimmune disease, an antinuclear antibody test was positive at a titer of 1:3200.
Our case is interesting for 2 reasons. First, it is a rare case of isolated SS. Thorough systemic evaluation showed no evidence of extracutaneous involvement. The literature only provides a few instances of isolated SS.6,7 Second, the sonographic appearance of SS is rare.8,9 Chen et al9 reported that gray-scale sonography revealed heterogenous, hypoechoic, well-demarcated plaquelike lesions with an intensive vascular pattern indicating Doppler hypervascularization. We obtained similar findings.
It has been widely acknowledged that sonographic findings of subcutaneous nodules tend to be nonspecific and overlapping. Color Doppler examination may show internal vessels both in malignant soft-tissue masses (eg, lymphoma, synovial sarcoma, liposarcoma, malignant fibrohistocytoma, metastases) and in benign lesions (eg, schwannoma, hemangioma, fibromatosis). However, the application of Doppler ultrasonography may restrict the diagnostic field, as it excludes nonvascularized benign masses such as lipomas as well as ganglion or epidermoid cysts. The ultimate diagnosis can only be made based on histopathology.
1. Vainsencher D, Winkelmann RK. Subcutaneous sarcoidosis. Arch Dermatol. 1984;120:1028-1031.
2. Marcoval J, Maña J, Moreno A, et al. Subcutaneous sarcoidosis—clinicopathological study of 10 cases. Br J Dermatol. 2005;153:790-794.
3. Ahmed I, Harshad SR. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease [published online ahead of print December 2, 2005]? J Am Acad Dermatol. 2006;54:55-60.
4. Dalle Vedove C, Colato C, Girolomoni G. Subcutaneous sarcoidosis: report of two cases and review of the literature [published online ahead of print April 2, 2011]. Clin Rheumatol. 2011;30:1123-1128.
5. Barnadas MA, Rodríguez-Arias JM, Alomar A. Subcutaneous sarcoidosis associated with vitiligo, pernicious anaemia and autoimmune thyroiditis. Clin Exp Dermatol. 2000;25:55-56.
6. Higgins EM, Salisbury JR, Du Vivier AW. Subcutaneous sarcoidosis. Clin Exp Dermatol. 1993;18:65-66.
7. Heller M, Soldano AC. Sarcoidosis with subcutaneous lesions. Dermatol Online J. 2008;14:1.
8. Bosni´c D, Baresi´c M, Bagatin D, et al. Subcutaneous sarcoidosis of the face [published online ahead of print March 15, 2010]. Intern Med. 2010;49:589-592.
9. Chen HH, Chen YM, Lan HH, et al. Sonographic appearance of subcutaneous sarcoidosis. J Ultrasound Med. 2009;28:813-816.
1. Vainsencher D, Winkelmann RK. Subcutaneous sarcoidosis. Arch Dermatol. 1984;120:1028-1031.
2. Marcoval J, Maña J, Moreno A, et al. Subcutaneous sarcoidosis—clinicopathological study of 10 cases. Br J Dermatol. 2005;153:790-794.
3. Ahmed I, Harshad SR. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease [published online ahead of print December 2, 2005]? J Am Acad Dermatol. 2006;54:55-60.
4. Dalle Vedove C, Colato C, Girolomoni G. Subcutaneous sarcoidosis: report of two cases and review of the literature [published online ahead of print April 2, 2011]. Clin Rheumatol. 2011;30:1123-1128.
5. Barnadas MA, Rodríguez-Arias JM, Alomar A. Subcutaneous sarcoidosis associated with vitiligo, pernicious anaemia and autoimmune thyroiditis. Clin Exp Dermatol. 2000;25:55-56.
6. Higgins EM, Salisbury JR, Du Vivier AW. Subcutaneous sarcoidosis. Clin Exp Dermatol. 1993;18:65-66.
7. Heller M, Soldano AC. Sarcoidosis with subcutaneous lesions. Dermatol Online J. 2008;14:1.
8. Bosni´c D, Baresi´c M, Bagatin D, et al. Subcutaneous sarcoidosis of the face [published online ahead of print March 15, 2010]. Intern Med. 2010;49:589-592.
9. Chen HH, Chen YM, Lan HH, et al. Sonographic appearance of subcutaneous sarcoidosis. J Ultrasound Med. 2009;28:813-816.
Inability to Grow Long Hair: A Presentation of Trichorrhexis Nodosa
To the Editor:
First identified by Samuel Wilks in 1852, trichorrhexis nodosa (TN) is a congenital or acquired hair shaft disorder that is characterized by fragile and easily broken hair.1 Congenital TN is rare and can occur in syndromes such as pseudomonilethrix, Netherton syndrome, pili annulati,2 argininosuccinic aciduria,3 trichothiodystrophy,4 Menkes syndrome,5 and trichohepatoenteric syndrome.6 The primary congenital form of TN is inherited as an autosomal-dominant trait in some families. Acquired TN is the most common hair shaft abnormality and often is overlooked. It is provoked by hair injury, usually mechanical or physical, or chemical trauma.7,8
Chemical trauma is caused by the use of permanent hair liquids or dyes. Mechanical injuries are the result of frequent brushing, scalp massage, or lengthy backcombing, and physical damage includes excessive UV exposure or repeated application of heat. Habit tics, trichotillomania, and the scratching and pulling associated with pruritic dermatoses also can result in sufficient damage to provoke TN. Furthermore, this acquired disorder may develop from malnutrition, particularly iron deficiency, or endocrinopathy such as hypothyroidism.9 Seasonal recurrence of TN has been reported from the cumulative effect of repeated soaking in salt water and exposure to UV light. Macroscopically, hair shafts affected by TN contain small white nodes at irregular intervals throughout the length of the hair shaft. These nodes represent areas of cuticular cell disruption, which allows the underlying cortical fibers to separate and fray and gives the node the microscopic appearance of 2 brooms or paintbrushes thrusting together end-to-end by the bristles. The classic description is known as paintbrush fracture.10 Generally, complete breakage occurs at these nodes.
A 21-year-old white woman presented to our clinic with hair fragility and inability to grow long hair of 2 years’ duration. The hair was lusterless and dry. Dermoscopic examination revealed broken blunt-ended hair of uneven length with minute pinpoint grayish white nodules (Figure 1). Small fragments could be easily broken off with gentle tugging on the distal ends. She reported a history of severe sunlight and seawater exposure during the last 2 summers and the continuous use of a flat iron in the last year. Microscopic examination of hair samples with a scanning electron microscope showed the characteristic paintbrush fracture (Figure 2). She had no history of diseases, and blood examinations including complete blood cell count, thyroid function test, and iron levels were within reference range.
![]() |
We hypothesize that the seasonal damage caused by exposure to UV light and salt water with repeated trauma from the heat of the flat iron caused distal TN. The patient was given an explanation about the diagnosis of TN and was instructed to avoid the practices that were suspected causes of the condition. Use of a gentle shampoo and conditioner also was recommended. At 6-month follow-up, we noticed an improvement of the quality of hair with a reduction in the whitish nodules and a revival of hair growth.
Acquired TN has been classified into 3 clinical forms: proximal, distal, and localized.1 Proximal TN is common in black individuals who use caustic chemicals when styling the hair. The involved hairs develop the characteristic nodes that break within a few centimeters from the scalp, especially in areas subject to friction from combing or sleeping. Distal TN primarily occurs in white or Asian individuals. In this disorder, nodes and breakage occur near the ends of the hairs that appear dull, dry, and uneven. Breakage commonly is associated with trichoptilosis, or longitudinal splitting, commonly referred to as split ends. This breakage may reflect frequent use of shampoo or heat treatments. The distal acquired form may simulate dandruff or pediculosis and the detection of this hair defect often is casual.
Localized TN, described by Raymond Sabouraud in 1921, is a rare disorder. It occurs in a patch that is usually a few centimeters long. It generally is accompanied by a pruritic dermatosis, such as circumscribed neurodermatitis, contact dermatitis, or atopic dermatitis. Scratching and rubbing most likely are the ultimate causes.
Trichorrhexis nodosa can spontaneously resolve. In all cases, diagnosis depends on careful microscopy examination and, if possible, scanning electron microscopy. Treatment is aimed at minimizing mechanical and physical injury, and chemical trauma. Excessive brushing, hot-combing, permanent waving, and other harsh hair treatments should be avoided. If the hair is long and the damage is distal, it may be sufficient to cut the distal fraction and to change cosmetic practices to prevent relapse.
Dermatologists who see patients with hair fragility and inability to grow long hair should consider the diagnosis of TN. Acquired TN often is reversible. Complete resolution may take 2 to 4 years depending on the growth of new anagen hairs. All patients with a history of white flecking on the scalp, abnormal fragility of the hair, and failure to attain normal hair length should be questioned about their routine hair care habits as well as environmental or chemical exposures to determine and remove the source of physical or chemical trauma.
1. Whiting DA. Structural abnormalities of hair shaft. J Am Acad Dermatol. 1987;16(1, pt 1):1-25.
2. Leider M. Multiple simultaneous anomalies of the hair; report of a case exhibiting trichorrhexis nodosa, pili annulati and trichostasis spinulosa. AMA Arch Derm Syphilol. 1950;62:510-514.
3. Allan JD, Cusworth DC, Dent CE, et al. A disease, probably hereditary characterised by severe mental deficiency and a constant gross abnormality of aminoacid metabolism. Lancet. 1958;1:182-187.
4. Liang C, Morris A, Schlücker S, et al. Structural and molecular hair abnormalities in trichothiodystrophy [published online ahead of print May 25, 2006]. J Invest Dermatol. 2006;126:2210-2216.
5. Taylor CJ, Green SH. Menkes’ syndrome (trichopoliodystrophy): use of scanning electron-microscope in diagnosis and carrier identification. Dev Med Child Neurol. 1981;23:361-368.
6. Hartley JL, Zachos NC, Dawood B, et al. Mutations in TTC37 cause trichohepatoenteric syndrome (phenotypic diarrhea of infancy)[published online ahead of print February 20, 2010]. Gastroenterology. 2010;138:2388-2398.
7. Chernosky ME, Owens DW. Trichorrhexis nodosa. clinical and investigative studies. Arch Dermatol. 1966;94:577-585.
8. Owens DW, Chernosky ME. Trichorrhexis nodosa; in vitro reproduction. Arch Dermatol. 1966;94:586-588.
9. Lurie R, Hodak E, Ginzburg A, et al. Trichorrhexis nodosa: a manifestation of hypothyroidism. Cutis. 1996;57:358-359.
10. Miyamoto M, Tsuboi R, Oh-I T. Case of acquired trichorrhexis nodosa: scanning electron microscopic observation. J Dermatol. 2009;36:109-110.
To the Editor:
First identified by Samuel Wilks in 1852, trichorrhexis nodosa (TN) is a congenital or acquired hair shaft disorder that is characterized by fragile and easily broken hair.1 Congenital TN is rare and can occur in syndromes such as pseudomonilethrix, Netherton syndrome, pili annulati,2 argininosuccinic aciduria,3 trichothiodystrophy,4 Menkes syndrome,5 and trichohepatoenteric syndrome.6 The primary congenital form of TN is inherited as an autosomal-dominant trait in some families. Acquired TN is the most common hair shaft abnormality and often is overlooked. It is provoked by hair injury, usually mechanical or physical, or chemical trauma.7,8
Chemical trauma is caused by the use of permanent hair liquids or dyes. Mechanical injuries are the result of frequent brushing, scalp massage, or lengthy backcombing, and physical damage includes excessive UV exposure or repeated application of heat. Habit tics, trichotillomania, and the scratching and pulling associated with pruritic dermatoses also can result in sufficient damage to provoke TN. Furthermore, this acquired disorder may develop from malnutrition, particularly iron deficiency, or endocrinopathy such as hypothyroidism.9 Seasonal recurrence of TN has been reported from the cumulative effect of repeated soaking in salt water and exposure to UV light. Macroscopically, hair shafts affected by TN contain small white nodes at irregular intervals throughout the length of the hair shaft. These nodes represent areas of cuticular cell disruption, which allows the underlying cortical fibers to separate and fray and gives the node the microscopic appearance of 2 brooms or paintbrushes thrusting together end-to-end by the bristles. The classic description is known as paintbrush fracture.10 Generally, complete breakage occurs at these nodes.
A 21-year-old white woman presented to our clinic with hair fragility and inability to grow long hair of 2 years’ duration. The hair was lusterless and dry. Dermoscopic examination revealed broken blunt-ended hair of uneven length with minute pinpoint grayish white nodules (Figure 1). Small fragments could be easily broken off with gentle tugging on the distal ends. She reported a history of severe sunlight and seawater exposure during the last 2 summers and the continuous use of a flat iron in the last year. Microscopic examination of hair samples with a scanning electron microscope showed the characteristic paintbrush fracture (Figure 2). She had no history of diseases, and blood examinations including complete blood cell count, thyroid function test, and iron levels were within reference range.
![]() |
We hypothesize that the seasonal damage caused by exposure to UV light and salt water with repeated trauma from the heat of the flat iron caused distal TN. The patient was given an explanation about the diagnosis of TN and was instructed to avoid the practices that were suspected causes of the condition. Use of a gentle shampoo and conditioner also was recommended. At 6-month follow-up, we noticed an improvement of the quality of hair with a reduction in the whitish nodules and a revival of hair growth.
Acquired TN has been classified into 3 clinical forms: proximal, distal, and localized.1 Proximal TN is common in black individuals who use caustic chemicals when styling the hair. The involved hairs develop the characteristic nodes that break within a few centimeters from the scalp, especially in areas subject to friction from combing or sleeping. Distal TN primarily occurs in white or Asian individuals. In this disorder, nodes and breakage occur near the ends of the hairs that appear dull, dry, and uneven. Breakage commonly is associated with trichoptilosis, or longitudinal splitting, commonly referred to as split ends. This breakage may reflect frequent use of shampoo or heat treatments. The distal acquired form may simulate dandruff or pediculosis and the detection of this hair defect often is casual.
Localized TN, described by Raymond Sabouraud in 1921, is a rare disorder. It occurs in a patch that is usually a few centimeters long. It generally is accompanied by a pruritic dermatosis, such as circumscribed neurodermatitis, contact dermatitis, or atopic dermatitis. Scratching and rubbing most likely are the ultimate causes.
Trichorrhexis nodosa can spontaneously resolve. In all cases, diagnosis depends on careful microscopy examination and, if possible, scanning electron microscopy. Treatment is aimed at minimizing mechanical and physical injury, and chemical trauma. Excessive brushing, hot-combing, permanent waving, and other harsh hair treatments should be avoided. If the hair is long and the damage is distal, it may be sufficient to cut the distal fraction and to change cosmetic practices to prevent relapse.
Dermatologists who see patients with hair fragility and inability to grow long hair should consider the diagnosis of TN. Acquired TN often is reversible. Complete resolution may take 2 to 4 years depending on the growth of new anagen hairs. All patients with a history of white flecking on the scalp, abnormal fragility of the hair, and failure to attain normal hair length should be questioned about their routine hair care habits as well as environmental or chemical exposures to determine and remove the source of physical or chemical trauma.
To the Editor:
First identified by Samuel Wilks in 1852, trichorrhexis nodosa (TN) is a congenital or acquired hair shaft disorder that is characterized by fragile and easily broken hair.1 Congenital TN is rare and can occur in syndromes such as pseudomonilethrix, Netherton syndrome, pili annulati,2 argininosuccinic aciduria,3 trichothiodystrophy,4 Menkes syndrome,5 and trichohepatoenteric syndrome.6 The primary congenital form of TN is inherited as an autosomal-dominant trait in some families. Acquired TN is the most common hair shaft abnormality and often is overlooked. It is provoked by hair injury, usually mechanical or physical, or chemical trauma.7,8
Chemical trauma is caused by the use of permanent hair liquids or dyes. Mechanical injuries are the result of frequent brushing, scalp massage, or lengthy backcombing, and physical damage includes excessive UV exposure or repeated application of heat. Habit tics, trichotillomania, and the scratching and pulling associated with pruritic dermatoses also can result in sufficient damage to provoke TN. Furthermore, this acquired disorder may develop from malnutrition, particularly iron deficiency, or endocrinopathy such as hypothyroidism.9 Seasonal recurrence of TN has been reported from the cumulative effect of repeated soaking in salt water and exposure to UV light. Macroscopically, hair shafts affected by TN contain small white nodes at irregular intervals throughout the length of the hair shaft. These nodes represent areas of cuticular cell disruption, which allows the underlying cortical fibers to separate and fray and gives the node the microscopic appearance of 2 brooms or paintbrushes thrusting together end-to-end by the bristles. The classic description is known as paintbrush fracture.10 Generally, complete breakage occurs at these nodes.
A 21-year-old white woman presented to our clinic with hair fragility and inability to grow long hair of 2 years’ duration. The hair was lusterless and dry. Dermoscopic examination revealed broken blunt-ended hair of uneven length with minute pinpoint grayish white nodules (Figure 1). Small fragments could be easily broken off with gentle tugging on the distal ends. She reported a history of severe sunlight and seawater exposure during the last 2 summers and the continuous use of a flat iron in the last year. Microscopic examination of hair samples with a scanning electron microscope showed the characteristic paintbrush fracture (Figure 2). She had no history of diseases, and blood examinations including complete blood cell count, thyroid function test, and iron levels were within reference range.
![]() |
We hypothesize that the seasonal damage caused by exposure to UV light and salt water with repeated trauma from the heat of the flat iron caused distal TN. The patient was given an explanation about the diagnosis of TN and was instructed to avoid the practices that were suspected causes of the condition. Use of a gentle shampoo and conditioner also was recommended. At 6-month follow-up, we noticed an improvement of the quality of hair with a reduction in the whitish nodules and a revival of hair growth.
Acquired TN has been classified into 3 clinical forms: proximal, distal, and localized.1 Proximal TN is common in black individuals who use caustic chemicals when styling the hair. The involved hairs develop the characteristic nodes that break within a few centimeters from the scalp, especially in areas subject to friction from combing or sleeping. Distal TN primarily occurs in white or Asian individuals. In this disorder, nodes and breakage occur near the ends of the hairs that appear dull, dry, and uneven. Breakage commonly is associated with trichoptilosis, or longitudinal splitting, commonly referred to as split ends. This breakage may reflect frequent use of shampoo or heat treatments. The distal acquired form may simulate dandruff or pediculosis and the detection of this hair defect often is casual.
Localized TN, described by Raymond Sabouraud in 1921, is a rare disorder. It occurs in a patch that is usually a few centimeters long. It generally is accompanied by a pruritic dermatosis, such as circumscribed neurodermatitis, contact dermatitis, or atopic dermatitis. Scratching and rubbing most likely are the ultimate causes.
Trichorrhexis nodosa can spontaneously resolve. In all cases, diagnosis depends on careful microscopy examination and, if possible, scanning electron microscopy. Treatment is aimed at minimizing mechanical and physical injury, and chemical trauma. Excessive brushing, hot-combing, permanent waving, and other harsh hair treatments should be avoided. If the hair is long and the damage is distal, it may be sufficient to cut the distal fraction and to change cosmetic practices to prevent relapse.
Dermatologists who see patients with hair fragility and inability to grow long hair should consider the diagnosis of TN. Acquired TN often is reversible. Complete resolution may take 2 to 4 years depending on the growth of new anagen hairs. All patients with a history of white flecking on the scalp, abnormal fragility of the hair, and failure to attain normal hair length should be questioned about their routine hair care habits as well as environmental or chemical exposures to determine and remove the source of physical or chemical trauma.
1. Whiting DA. Structural abnormalities of hair shaft. J Am Acad Dermatol. 1987;16(1, pt 1):1-25.
2. Leider M. Multiple simultaneous anomalies of the hair; report of a case exhibiting trichorrhexis nodosa, pili annulati and trichostasis spinulosa. AMA Arch Derm Syphilol. 1950;62:510-514.
3. Allan JD, Cusworth DC, Dent CE, et al. A disease, probably hereditary characterised by severe mental deficiency and a constant gross abnormality of aminoacid metabolism. Lancet. 1958;1:182-187.
4. Liang C, Morris A, Schlücker S, et al. Structural and molecular hair abnormalities in trichothiodystrophy [published online ahead of print May 25, 2006]. J Invest Dermatol. 2006;126:2210-2216.
5. Taylor CJ, Green SH. Menkes’ syndrome (trichopoliodystrophy): use of scanning electron-microscope in diagnosis and carrier identification. Dev Med Child Neurol. 1981;23:361-368.
6. Hartley JL, Zachos NC, Dawood B, et al. Mutations in TTC37 cause trichohepatoenteric syndrome (phenotypic diarrhea of infancy)[published online ahead of print February 20, 2010]. Gastroenterology. 2010;138:2388-2398.
7. Chernosky ME, Owens DW. Trichorrhexis nodosa. clinical and investigative studies. Arch Dermatol. 1966;94:577-585.
8. Owens DW, Chernosky ME. Trichorrhexis nodosa; in vitro reproduction. Arch Dermatol. 1966;94:586-588.
9. Lurie R, Hodak E, Ginzburg A, et al. Trichorrhexis nodosa: a manifestation of hypothyroidism. Cutis. 1996;57:358-359.
10. Miyamoto M, Tsuboi R, Oh-I T. Case of acquired trichorrhexis nodosa: scanning electron microscopic observation. J Dermatol. 2009;36:109-110.
1. Whiting DA. Structural abnormalities of hair shaft. J Am Acad Dermatol. 1987;16(1, pt 1):1-25.
2. Leider M. Multiple simultaneous anomalies of the hair; report of a case exhibiting trichorrhexis nodosa, pili annulati and trichostasis spinulosa. AMA Arch Derm Syphilol. 1950;62:510-514.
3. Allan JD, Cusworth DC, Dent CE, et al. A disease, probably hereditary characterised by severe mental deficiency and a constant gross abnormality of aminoacid metabolism. Lancet. 1958;1:182-187.
4. Liang C, Morris A, Schlücker S, et al. Structural and molecular hair abnormalities in trichothiodystrophy [published online ahead of print May 25, 2006]. J Invest Dermatol. 2006;126:2210-2216.
5. Taylor CJ, Green SH. Menkes’ syndrome (trichopoliodystrophy): use of scanning electron-microscope in diagnosis and carrier identification. Dev Med Child Neurol. 1981;23:361-368.
6. Hartley JL, Zachos NC, Dawood B, et al. Mutations in TTC37 cause trichohepatoenteric syndrome (phenotypic diarrhea of infancy)[published online ahead of print February 20, 2010]. Gastroenterology. 2010;138:2388-2398.
7. Chernosky ME, Owens DW. Trichorrhexis nodosa. clinical and investigative studies. Arch Dermatol. 1966;94:577-585.
8. Owens DW, Chernosky ME. Trichorrhexis nodosa; in vitro reproduction. Arch Dermatol. 1966;94:586-588.
9. Lurie R, Hodak E, Ginzburg A, et al. Trichorrhexis nodosa: a manifestation of hypothyroidism. Cutis. 1996;57:358-359.
10. Miyamoto M, Tsuboi R, Oh-I T. Case of acquired trichorrhexis nodosa: scanning electron microscopic observation. J Dermatol. 2009;36:109-110.